Animal/Tissue Order List
1 - 1224 / total 1224
Order | Amimal |
Tissue |
JCRB No. |
Cell Name |
Profile |
|
---|---|---|---|---|---|---|
bovine:blastcyst Top | ||||||
Ask to JCRB | bovine | blastcyst | JCRB1981 | BT-J | bovine trophoblastic cell line | |
bovine:blastcyto Top | ||||||
Ask to JCRB | bovine | blastcyto | JCRB1955 | BT-F | bovine trophoblastic cell line | |
bovine:cornea Top | ||||||
Japan Domestic use only | bovine | cornea | JCRB9129 | BCE C/D-1b | Bovine corneal endothelial cell line. | |
bovine:kidney Top | ||||||
Japan Domestic use only | bovine | kidney | JCRB0008 | CKT-1 | useful to assay bovine adenovirus 3 | |
Japan Domestic use only | bovine | kidney | IFO50003 | CKT-1 | This cell line is useful to produce and assay bovine adinovirus 3 in vitro. (J. Virol., 16, 621 (1975)). CKT-1 is a clone of CKT. | |
Japan Domestic use only | bovine | kidney | JCRB9028 | MDBK (NBL-1) | established from normal kidney | |
Japan Domestic use only | bovine | kidney | JCRB0716 | MDBK.P3 | normal kidney, MDBK derivative, no serum required | |
bovine:lung Top | ||||||
Japan Domestic use only | bovine | lung | JCRB9038 | EBTr (NBL-4) | embryonic trachea | |
bovine:trophoblast Top | ||||||
Ask to JCRB | bovine | trophoblast | JCRB1927 | BT-A | bovine trophoblastic cell line | |
Ask to JCRB | bovine | trophoblast | JCRB1935 | BT-B | bovine trophoblastic cell line | |
Ask to JCRB | bovine | trophoblast | JCRB1936 | BT-D | bovine trophoblastic cell line | |
bovine:vascular system Top | ||||||
Japan Domestic use only | bovine | vascular system | JCRB9025 | CPA | pulmonary artery normal endothelial cell | |
Japan Domestic use only | bovine | vascular system | JCRB9022 | CPAE | pulmonary artery normal endothelial cell | |
Japan Domestic use only | bovine | vascular system | IFO50154 | FBHE | Normal diploid endothelial cells with limited life span. FGF-dependent for survival. | |
Japan Domestic use only | bovine | vascular system | JCRB0099 | HH | carotid artery normal endothelial cell | |
Japan Domestic use only | bovine | vascular system | JCRB0155 | NM-1 | Newly established primary bovine cell line established from artery which is confirmed to be free from BVDV contamination. | |
cat:kidney Top | ||||||
cat | kidney | JCRB9035 | CRFK | kidney, BVD antigen negative | ||
cat:neural Top | ||||||
cat | neural | JCRB9125 | PG-4(S+L-) | brain derived cell line transformed with Moloney murine sarcoma virus, support type C retroviruses | ||
chicken:hemo-lymphocytic Top | ||||||
Japan Domestic use only | chicken | hemo-lymphocytic | JCRB9130 | DT40 | avian leukosis virus (ALV)-induced lymphomas | |
chicken:liver Top | ||||||
Japan Domestic use only | chicken | liver | JCRB0237 | LMH | hepatocelluler carcinoma, diethylnitrosamine induced | |
chimpanzee:hemo-lymphocytic Top | ||||||
Japan Domestic use only | chimpanzee | hemo-lymphocytic | JCRB1165 | HSP-239 | Peripheral blood lymphocyte cell line of chimpanzee. | |
Japan Domestic use only | chimpanzee | hemo-lymphocytic | JCRB1177 | HSP-250 | Peripheral blood lymphocyte cell line of chimpanzee. | |
dog:kidney Top | ||||||
dog | kidney | JCRB9029 | MDCK (NBL-2) | established from normal kidney, susceptible for many viral species | ||
dog | kidney | IFO50071 | MDCK (NBL-2) | Epitherial-like cell line established from normal kidney of dog, susceptible for many viral species. | ||
dog | kidney | JCRB0717 | MDCK.P3 | normal kidney, MDCK derivative, no serum required | ||
dog:lung Top | ||||||
dog | lung | JCRB1453 | CLAC | Canine lung adenocarcinoma cell line including cancer stem cells (0.75%) in sidepopulation (SP). | ||
goat:esophagus Top | ||||||
Japan Domestic use only | goat | esophagus | JCRB9037 | Ch 1 Es | Fibroblastic cell line from normal fetal goat esophagus. | |
guinea pig:embryo Top | ||||||
guinea pig | embryo | JCRB9036 | 104C1 | fetal carcass, benzo(a)pyrene transformed, diploid | ||
guinea pig:hemo-lymphocytic Top | ||||||
guinea pig | hemo-lymphocytic | IFO50210 | L2C | Leukemic cells derived from Guinea pig maintainable only by transplantation. | ||
hamster, Chinese:lung Top | ||||||
hamster, Chinese | lung | JCRB1105 | AIG | anchorage-independent mutant of CHL | ||
hamster, Chinese | lung | JCRB0030 | CHL/IU(IVGT) | Chinese hamster lung cells. Standard cell line for chromosome aberation test. | ||
hamster, Chinese | lung | JCRB1102 | cs-17-25 | Temperature sensitive mutant of Chinese hamster lung cell line. | ||
hamster, Chinese | lung | JCRB1103 | cs-19-36 | Temperature sensitive mutant of Chinese hamster lung cell line. | ||
hamster, Chinese | lung | JCRB1104 | cs-20-5 | temperature sensitive mutant of Chinese hamster lung cell line. | ||
hamster, Chinese | lung | JCRB1096 | hs-103-3 | Temperature sensitive mutant of Chinese hamster lung cell line. | ||
hamster, Chinese | lung | JCRB1097 | hs-164-2 | Temperature sensitive mutant of Chinese hamster lung cell line. | ||
hamster, Chinese | lung | JCRB1098 | hs-171-1 | Temperature sensitive mutant of Chinese hamster lung cell line. | ||
hamster, Chinese | lung | JCRB1099 | hs-172-3 | Temperature sensitive mutant of Chines hamster lung cell line. | ||
hamster, Chinese | lung | JCRB1100 | hs-211 | Temperature sensitive mutant of Chinese hamster lung cell line. | ||
hamster, Chinese | lung | JCRB1101 | hs-222-3 | temperature sensitive mutant of Chinese hamster lung cell line. | ||
hamster, Chinese | lung | JCRB0626 | TG1 | V79 derivative, 6-thioguanine-resistant | ||
hamster, Chinese | lung | JCRB0603 | V79 | fibroblast | ||
hamster, Chinese | lung | IFO50082 | V79 379A | lung, fibroblast, widely used in somatic genetics | ||
hamster, Chinese | lung | JCRB0707 | V79 HPRT~ | V79 derivative, HPRT-deficient | ||
hamster, Chinese | lung | JCRB0219 | V79-6TG | 6-thioguanine-resistant V79 cell line | ||
hamster, Chinese | lung | JCRB0119 | YG10003 | salmonella O-acetyltransferase gene introduced CHL cells | ||
hamster, Chinese | lung | JCRB0120 | YG10007 | human monomorphic N-acetyltransferase gene introduced CHL cells | ||
hamster, Chinese | lung | JCRB0121 | YG10008 | human polymorphic N-acetyltransferase gene transfected CHL cells | ||
hamster, Chinese:ovary Top | ||||||
hamster, Chinese | ovary | JCRB0136.2 | CHO(pMAM-HSluc) | pMAM-HSluc transfected CHO-K1, HSP 70B gene promoter and luciferase reporter gene introduced | ||
hamster, Chinese | ovary | JCRB0136.1 | CHO(pMAM-luc) | pMAM-luc transfected CHO-K1, luciferase activated by dexamethasone | ||
hamster, Chinese | ovary | JCRB9018 | CHO-K1 | subclone of CHO (Chainese hamster ovary) cells | ||
hamster, Chinese | ovary | IFO50414 | CHO-K1 | CHO-K1 cells are useful for isolation of nutritionally deficient mutants. | ||
hamster, Chinese | ovary | JCRB0218 | CHO/HGPRT | HGPRT deficient chinese hamster ovary (CHO) cells. | ||
hamster, Chinese | ovary | JCRB1616 | hTf/CHO-S #17 | This cell line produce human transferrin. | ||
hamster, Chinese | ovary | JCRB1629 | hTf/CHO-S #17/sf | This cell line produce human transferrin (cell freezed by 10% DMSO+90%FBS). | ||
hamster, Chinese | ovary | JCRB1629.01 | hTf/CHO-S #17/sf | This cell line produce human transferrin (cell freezed by Cryoprotective Medium). | ||
hamster, Chinese | ovary | JCRB1631 | hTf/CHO-S #29/sf | This cell line produce human transferrin (cell freezed by 10% DMSO + 90% FBS). | ||
hamster, Chinese | ovary | JCRB1631.01 | hTf/CHO-S #29/sf | This cell line produce human transferrin (cell freezed by Cryoprotective Medium). | ||
hamster, Chinese | ovary | JCRB1636 | pREP4 c/CHO-S #5/sf | pREP4-cont transfected CHO-S cells (cell freezed by 10% DMSO + 90% FBS). | ||
hamster, Chinese | ovary | JCRB1636.01 | pREP4 c/CHO-S #5/sf | pREP4-cont transfected CHO-S cells (cell freezed by Cryoprotective Medium). | ||
hamster, Chinese | ovary | JCRB1626 | pREP4 cont/CHO-S #5 | pREP4-cont transfected CHO-S cells (cell freezed by 10% DMSO + 90% FBS). | ||
hamster, Syrian:embryo Top | ||||||
hamster, Syrian | embryo | JCRB0217 | DSPT200 | fetus fibroblast transformed cell | ||
hamster, Syrian | embryo | IFO50018 | NIL | transformed from hamster fibroblast | ||
hamster, Syrian | embryo | IFO50426 | NIL-SF2 | NIL subline adapted to serum-free medium | ||
hamster, Syrian | embryo | IFO50367 | SHOK | This cell line is useful for transformation assay. | ||
hamster, Syrian:hemo-lymphocytic Top | ||||||
hamster, Syrian | hemo-lymphocytic | JCRB1362 | HCT-2 | Hamster spleen lymphocytes transformed by human T-cell leukemia virus type I. | ||
hamster, Syrian | hemo-lymphocytic | JCRB1208 | HM-1 | Hamster macrophage cell line from Syrian hamster transplanted with human umbilical cord leukocytes. | ||
hamster, Syrian:kidney Top | ||||||
hamster, Syrian | kidney | JCRB9020 | BHK-21(C-13) | kidney, subclone of BHK-21 | ||
hamster, Syrian:lung Top | ||||||
hamster, Syrian | lung | JCRB0221 | HT100 | lung, new born | ||
hamster, Syrian:melanoma Top | ||||||
hamster, Syrian | melanoma | JCRB9087 | RPMI 1846 | melanotic melanoma | ||
human:adrenal cortex Top | ||||||
human | adrenal cortex | JCRB9069 | SW-13 | Human adenocarcinoma derived from adrenal cortex. | ||
human:bile duct Top | ||||||
human | bile duct | JCRB1657 | HuCCA-1 | Human cell line derived from cholangiocarcinoma. | ||
human | bile duct | JCRB1775 | KKK-D068 | Human well differentiated tubular adenocarcinma cell line established from biliary tract. (with micropapillary foci) | ||
human | bile duct | JCRB1777 | KKK-D131 | Human well differentiated tubular adenocarcinoma cell line established from biliary tract. | ||
human | bile duct | JCRB1778 | KKU-023 | Human well differentiated cholangiocarcinoma cell line established from biliary tract. | ||
human:bladder Top | ||||||
human | bladder | JCRB0710 | EJ-1 | The cell line EJ-1 was identified to be the same cell line as the T24. | ||
human | bladder | JCRB1148 | KMBC-2 | Urinary bladder cancer cell line | ||
human | bladder | JCRB0711 | T24 | urinary bladder carcinoma | ||
human:blood Top | ||||||
human | blood | JCRB1972 | Kit225 | IL-2 dependent T-cell chronic lymphocytic leukemia (T-CLL) cell line | ||
human:bone marrow stroma Top | ||||||
human | bone marrow stroma | IFO50477 | FS-1 | This cell line produces IL-6 and SCF into its supernatant. Although this cell line was reported as immortalized cell line, the ampoules preserved in the cell bank hardly proliferated. | ||
human:cartilage Top | ||||||
human | cartilage | JCRB1137 | UE6E7TC-4 | Human immortalized mesenchymal cells derived from dedifferentiated chondrocyte, expressing mesenchymal stem cell markers. | ||
human:cerebral tumor Top | ||||||
human | cerebral tumor | JCRB1868 | AT/RT | atypical teratoid/rhabdoid tumor | ||
human:colon Top | ||||||
human | colon | IFO50483 | CCD-33Co | Human fibroblast cell line established from normal colon. The ampoules preserved in the cell bank hardly proliferate. | ||
human | colon | JCRB0208 | CCK-81 | adenocarcinoma | ||
human | colon | JCRB0257 | CoCM-1 | Human tumor cell line of the moderately differentiated adenocarcinoma from descending colon. | ||
human | colon | JCRB0226 | COLO201 | adenocarcinoma | ||
human | colon | JCRB0225 | COLO320 DM | Human colon carcinoma cell line with double minute chromosomes. | ||
human | colon | JCRB9094 | DLD-1 | adenocarcinoma | ||
human | colon | JCRB1998 | KE-24 | poorly differentiated adenocarcinoma (signet-ring cell type) established from primary tumor. | ||
human | colon | JCRB4003 | KE-43 | moderately differentiated adenocarcinoma established from primary tumor. Transition to poorly differentiated adenocarcinoma by passage. | ||
human | colon | JCRB4004 | KE-43C4 | Well-differentiated adenocarcinoma obtained by cloning KE-43 | ||
human | colon | JCRB9083 | LoVo | adenocarcinoma, carcinoembryonic antigen-producing | ||
human | colon | IFO50067 | LoVo | adenocarcinoma, carcinoembryonic antigen-producing | ||
human | colon | JCRB1339 | NCC-CoC-K115B | Human B-cell line (transformed by EBV) derived from colon cancer patient. | ||
human | colon | JCRB1333 | NCC-CoC-K115L | Human colon cancer cell line (metastasis peripheral lymph node). | ||
human | colon | JCRB1320 | NCC-CoC-K115P | Human colon cancer cell line. | ||
human | colon | JCRB1022 | OUMS-23 | A human colon carcinoma cell line established from metastatic pericardial fluid. | ||
human | colon | JCRB1963 | UCCA-21 | Derived from colorectal cancer with ulcerative colitis. Isolated as well-differentiated adenocarcinoma by cloning. Paneth cells included. | ||
human | colon | JCRB0224 | WiDr | adenocarcinoma | ||
human | colon | IFO50043 | WiDr | adenocarcinoma | ||
human:duodenum Top | ||||||
human | duodenum | JCRB1946 | AkuNEC | Cachexia-inducing cell line, (established from duodenal neuroendocrine carcinoma TCC-NECT-2) | ||
human | duodenum | JCRB1916 | TCC-NECT-2 | Duodenal neuroendocrine tumor. Derived from metastatic site: Ascites. | ||
human:embryo Top | ||||||
human | embryo | IFO50297 | HE-1 | Normal diploid fibroblasts with limited life span. | ||
human | embryo | JCRB0432 | KMS-6 | fibroblast, normal diploid | ||
human | embryo | JCRB0433 | KMST-6 | fibroblast, immortalized by 60Co irradiation, derivative of KMS-6 | ||
human | embryo | JCRB0220 | NTI-4 | Normal human fibroblast. | ||
human | embryo | JCRB0222 | NTI-5 | Normal human cells. | ||
human | embryo | JCRB1051 | OUMS-24/P6X | Human normal cells immortalized by pCDM8-p53 and X-ray irradiation. | ||
human | embryo | JCRB1006.0 | OUMS-36 | Normal human embryo fibroblast cell. | ||
human | embryo | JCRB1006.1 | OUMS-36T-1 | hTRT gene transfected normal human embryo fibroblast cell line. | ||
human | embryo | JCRB1006.1F | OUMS-36T-1F | fibroblast, immortalized by hTRT, derivative of OUMS-36 | ||
human | embryo | JCRB1006.2 | OUMS-36T-2 | hTRT gene transfected normal human embryo fibroblast cell line. | ||
human | embryo | JCRB1006.2F | OUMS-36T-2F | fibroblast, immortalized by hTRT, derivative of OUMS-36 | ||
human | embryo | JCRB1006.3 | OUMS-36T-3 | hTRT gene transfected normal human embryo fibroblast cell line. | ||
human | embryo | JCRB1006.3F | OUMS-36T-3F | Human normal diploid cells transfected with hTRT gene | ||
human | embryo | JCRB1006.4 | OUMS-36T-4 | hTRT gene transfected normal human embryo fibroblast cell line. | ||
human | embryo | JCRB1006.4F | OUMS-36T-4F | Immortalized normal human cell with hTRT gene. | ||
human | embryo | JCRB1006.5 | OUMS-36T-5 | hTRT gene transfected normal human embryo fibroblast cell line. | ||
human | embryo | JCRB1006.5F | OUMS-36T-5F | fibroblast, immortalized by hTRT, derivative of OUMS-36 | ||
human | embryo | JCRB1006.6 | OUMS-36T-6 | hTRT gene transfected normal human embryo fibroblast cell line. | ||
human | embryo | JCRB1006.6F | OUMS-36T-6F | fibroblast, immortalized by hTRT, derivative of OUMS-36 | ||
human | embryo | JCRB1006.7 | OUMS-36T-7 | hTRT gene transfected normal human embryo fibroblast cell line. | ||
human | embryo | JCRB1006.7F | OUMS-36T-7F | Human normal fibroblast transformed with hTRT gene. | ||
human | embryo | JCRB1006.8 | OUMS-36T-8 | hTRT gene transfected normal human embryo fibroblast cell line. | ||
human | embryo | JCRB1006.8F | OUMS-36T-8F | fibroblast, immortalized by hTRT, derivative of OUMS-36 | ||
human:epidermoid carcinoma Top | ||||||
human | epidermoid carcinoma | JCRB0004 | A-431 | epidermoid carcinoma, high expression of EGF-receptor | ||
human | epidermoid carcinoma | JCRB9009 | A-431 | epidermoid carcinoma, high expression of EGF-receptor | ||
human | epidermoid carcinoma | IFO50411 | A-431 | epidermoid carcinoma, high expression of EGF receptor | ||
human:esophagus Top | ||||||
human | esophagus | JCRB1883 | KE-3 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | ||
human | esophagus | JCRB1911 | KE-5 | Human well differentiated squamous cell carcinoma cell line established from esophageal cancer. | ||
human | esophagus | JCRB1915 | KE-6 | Human well differentiated squamous cell carcinoma cell line established from esophageal cancer. | ||
Japan Domestic use only | human | esophagus | JCRB1483 | KYAE-1 | Human esophageal adenocarcinoma cell line. | |
Japan Domestic use only | human | esophagus | JCRB1595 | KYAE-2 | Human esophageal adenocarcinoma cell line. | |
Japan Domestic use only | human | esophagus | JCRB1064 | KYSE110 | Poorly differentiated squamous carcinoma cell line from human esophagus cancer. | |
Japan Domestic use only | human | esophagus | JCRB1449 | KYSE1140 | Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1457 | KYSE1170 | Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1421 | KYSE1190 | Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1444 | KYSE1230 | Human spindle cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1456 | KYSE1240 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1462 | KYSE1250 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1434 | KYSE1260 | Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1063 | KYSE140 | Human esophageal cancer cell line. | |
Japan Domestic use only | human | esophagus | JCRB1432 | KYSE1440 | Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1095 | KYSE150 | Poorly differentiated squamous carcinoma cell line from human esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1082 | KYSE170 | Human squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1083 | KYSE180 | Human well differentiated squamous cell carcinoma from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1460 | KYSE1860 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1426 | KYSE190 | Human well differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1086 | KYSE220 | Human squamous cell carcinoma from esophagus. | |
Japan Domestic use only | human | esophagus | JCRB1468 | KYSE2270 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1472 | KYSE2300 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1424 | KYSE2400 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1087 | KYSE270 | Human squamous cell carcinoma from esophagus cancer. | |
Japan Domestic use only | human | esophagus | JCRB1467 | KYSE2710 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1452 | KYSE2780 | Human squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1469 | KYSE2880 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB0188 | KYSE30 | Well differentiated human suamous cell carcinoma from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1463 | KYSE3210 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1425 | KYSE3410 | Human squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1428 | KYSE350 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1495 | KYSE3650 | Human squamous cell carcinoma cell line established from recurrent cancer (esophageal cancer). | |
Japan Domestic use only | human | esophagus | JCRB1481 | KYSE3940 | moderate differenciated squamous cell carcinoma, stage 3 | |
Japan Domestic use only | human | esophagus | JCRB1419 | KYSE410 | Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1430 | KYSE450 | Human well differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB0189 | KYSE50 | Stop providing for the issue of quality control. (Please contact us for more information) Poorly differentiated human squamous cell carcinoma from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1436 | KYSE510 | Human well differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1439 | KYSE520 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1443 | KYSE590 | Human well differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB0190 | KYSE70 | Poorly differentiated human squamous cell carcinoma from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1445 | KYSE770 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1418 | KYSE790 | Human well differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1422 | KYSE850 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
Japan Domestic use only | human | esophagus | JCRB1417 | KYSE960 | Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. | |
human | esophagus | JCRB0262 | T.T | Human squamous cell carcinoma derived from esophageal cancer. | ||
human | esophagus | JCRB0261 | T.Tn | Human squamous cell carcinoma from oral cavity via mouse transplantation. | ||
Japan Domestic use only | human | esophagus | JCRB1512 | TYUC-1 | Human esophageal small cell carcinoma cell line established from mouse xenograft. | |
human:glioblastoma Top | ||||||
human | glioblastoma | IFO50492 | AM-38 | glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-sensitive | ||
human:glioma Top | ||||||
human | glioma | IFO50356 | KNS-42 | glioma, GFAP-positive, S-100 and NSE-negative | ||
human | glioma | JCRB1569 | NP 5 | Human cell line derived from human glioma. | ||
human:HeLa-contaminant Top | ||||||
human | HeLa-contaminant | JCRB9066 | Chang Liver | The Chang Liver cell line has been identified historically as a subline of the HeLa. | ||
human | HeLa-contaminant | IFO50016 | Chang Liver | Hela markers* | ||
human | HeLa-contaminant | JCRB1070 | HSGc-C5 | Human undifferentiated carcinoma cell line from floor of mouth (HeLa evidences observed). | ||
human | HeLa-contaminant | JCRB0073 | J-111 | The cell line deposited as a human acute monocytic leukemia but many data show this cell line is a subline of the HeLa. | ||
human | HeLa-contaminant | IFO50005 | J-111 | HeLa markers* | ||
human | HeLa-contaminant | JCRB9027 | KB | The cell line KB has been known that this cell line is a subline of the HeLa. | ||
human | HeLa-contaminant | IFO50004 | WISH | Cells were reported to established from human aminion but later HeLa markers were observed. | ||
human:hemo-lymphocytic Top | ||||||
human | hemo-lymphocytic | JCRB0097 | A4/Fuk | lymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing | ||
human | hemo-lymphocytic | JCRB0117 | B104 | Human B cell lymphoma cell line with EBNA(-). IgD and IgM were expressed on the surface of cells. | ||
human | hemo-lymphocytic | JCRB0071 | BALL-1 | Acute lymphoblastoid leukemia (ALL) cell line from human. | ||
human | hemo-lymphocytic | JCRB0033 | CCRF-CEM | leukemia, acute T lymphoblastic | ||
human | hemo-lymphocytic | JCRB9023 | CCRF-CEM | Human cell line established from patient with acute lymphoblastic leukemia. | ||
human | hemo-lymphocytic | IFO50412 | CCRF-CEM | leukemia, acute T lymphoblastic | ||
human | hemo-lymphocytic | JCRB0031 | CCRF-HSB2 | Human T-lymphoblastic leukemia cell line from implanted tumor in Syrian hamster. | ||
human | hemo-lymphocytic | IFO50026 | CCRF-SB | Karyotypes appeared normal diploid. This cell line does not synthesize immunogloblins. | ||
human | hemo-lymphocytic | IFO50430 | CMK-11-5 | This cell line posseses more mature characteristics than CMK-86 cells. | ||
human | hemo-lymphocytic | IFO50428 | CMK-86 | This cell line expresses GPIIb/IIIa. Contains alpha-granule. Contains platelet peroxidase activity. | ||
human | hemo-lymphocytic | JCRB1067 | CPT-K5 | Mutant cell line derived from human ALL cell line, RPMI8402. | ||
human | hemo-lymphocytic | JCRB1344 | delta-47 | Human myeloma cell line secreting IgD. | ||
human | hemo-lymphocytic | JCRB1337 | DL-40 | Ki-1-positive T-cell lymphoma cell line. | ||
human | hemo-lymphocytic | JCRB1346 | FLAM-76 | Interleukin-6-dependent human myeloma cell line from an agressive nonsecretory plasma cell leukemia. | ||
human | hemo-lymphocytic | JCRB1335 | HD-70 | Human Hodgkin's lymphoma cell line of B-cell origin. | ||
human | hemo-lymphocytic | JCRB0062 | HEL | leukemia, erythroid | ||
human | hemo-lymphocytic | IFO50022 | HL-60 | IFO strain exhibits more rapid growth compared to the original HL-60 strain. IFO strain does not respond to DMSO or TPA for differentiation unlike to original HL-60 strain. | ||
human | hemo-lymphocytic | JCRB0085 | HL60 | Promyelocytic cell line differentiated to neutrophils or macropahges by tumor promoters, vitamne D3 or cytekines. The cell line can be used for the research of the differenciation induction or analysis of some oncogenes. | ||
human | hemo-lymphocytic | JCRB0163 | HL60(S) | Promyeloblastic cell line differentiated to neutrophils or macropahges by tumor promoters, vitamne D3 or cytekines. This HL60(S) has been independently obtained by Dr. Ishida,S. and Dr. Shudo,K. | ||
human | hemo-lymphocytic | JCRB0006 | HL60RG | Subline of the HL60 having faster growth rate but the capabilities of the differentiation by TPA or etc were declined. | ||
human | hemo-lymphocytic | JCRB0041 | HLCL-1 | lymphocyte, peripheral | ||
human | hemo-lymphocytic | JCRB9062 | HS-Sultan | established as plasmacytoma, but revealed as derivative of Jiyoye cell line (Burkitt's lymphoma) | ||
human | hemo-lymphocytic | JCRB0024 | IM-9 | myeloma, multiple, B lymphoblastic | ||
human | hemo-lymphocytic | IFO50025 | IM-9 | IgG-secreting B-lymphoblastic cell line. | ||
human | hemo-lymphocytic | JCRB0147 | JKT-beta-del | The JKT-beta-del cell line isolated from the Jurkat cells{5011} by a cell sorter and lacks the surface expression of the T-cell receptor alpha/beta/CD3 complex. | ||
human | hemo-lymphocytic | JCRB0019 | K562 | Highly undifferentiated and granurocytic myelogenous leukemia cell line from blast crisis. | ||
human | hemo-lymphocytic | JCRB1002 | K562/ADM | Adriamycine resistant derivative of K562 cell line. | ||
human | hemo-lymphocytic | JCRB1003 | Kasumi-1 | A novel leukemia cell line with an t8;21 chromosome translocation established from a patient attaked by acute myeloid leukemia(AML). | ||
human | hemo-lymphocytic | JCRB1410 | Kasumi-10 | B cell leukemia | ||
human | hemo-lymphocytic | JCRB0161 | Kasumi-4 | A novel human leukemia cell line established from a patient with chronic myelogenous leukaemia (CML) in blast crisis. | ||
human | hemo-lymphocytic | JCRB1398 | Kasumi-5 | T cell leukemia | ||
human | hemo-lymphocytic | JCRB1401 | Kasumi-7 | B cell leukemia | ||
human | hemo-lymphocytic | JCRB1403 | Kasumi-8 | B cell leulemia | ||
human | hemo-lymphocytic | JCRB1409 | Kasumi-9 | B cell leukemia | ||
human | hemo-lymphocytic | JCRB1411 | KasumiA-541 | mixed lineage leukemia | ||
human | hemo-lymphocytic | JCRB1416 | KasumiA-554 | myeloid leukemia secondary to ATL | ||
human | hemo-lymphocytic | JCRB1415 | KasumiA-568 | myeloblastic leukemia | ||
human | hemo-lymphocytic | JCRB1317 | KCL-22 | Human myeloid cell line from chronic myelocytic leukemia. | ||
human | hemo-lymphocytic | JCRB0065 | KG-1 | leukemia, acute myeloblastic | ||
human | hemo-lymphocytic | JCRB9051 | KG-1 | leukemia, acute myelogenous | ||
human | hemo-lymphocytic | JCRB0165 | KHM-10B | Human Bukitt's lymphoma, ALL-L3 cell line. HLA-DR,CD19 and surface immunoglobulin(mu, lambda) positive. Ig gene rearrangements observed. | ||
human | hemo-lymphocytic | JCRB1394 | KHM-2B | Human acute B-cell lymphocytic leukemia cell line with two translocations t(8;14) and t(14;18). | ||
human | hemo-lymphocytic | JCRB1065 | Ki-JK | Human mononuclear cells with multiple nucleoli from lymphoma patient. | ||
human | hemo-lymphocytic | JCRB1180 | KMM-1 | human myeloma cell line | ||
human | hemo-lymphocytic | JCRB0123 | KO52 | leukemia, acute myeloblastic | ||
human | hemo-lymphocytic | JCRB0104 | KU812 | leukemia, chronic myeloid | ||
human | hemo-lymphocytic | IFO50363 | KU812 | leukemia, chronic myeloid | ||
human | hemo-lymphocytic | JCRB0104.1 | KU812E | leukemia, chronic myeloid | ||
human | hemo-lymphocytic | JCRB0104.2 | KU812F | leukemia, chronic myeloid | ||
human | hemo-lymphocytic | JCRB0105 | KY821 | leukemia, acute myeloid | ||
human | hemo-lymphocytic | JCRB0105.1 | KY821A3 | leukemia, acute myeloid, subclone of KY821 | ||
human | hemo-lymphocytic | JCRB0114 | LC4-1 | leukemia, acute non T lymphoblastic | ||
human | hemo-lymphocytic | IFO50151 | MEG-01 | Contains Ph1 chromosome. Expresses megakaryoblastic markers as GPIIb/IIIa, GPIb, FVIII-related antigens, and also CD9, CDw14. It is reported that MEG-01 cells produced platelet-like particles. Morphological changes by phorbol ester. | ||
human | hemo-lymphocytic | IFO50473 | MEG-01s | This cell line is useful for studying the differentiation and maturation of megakaryocyts. | ||
human | hemo-lymphocytic | IFO50294 | MEG-01SSF | leukemia, chronic megakaryoblastic, MEG-01s-derivative adapted to serum-free medium | ||
human | hemo-lymphocytic | IFO50478 | MEG-A2 | This cell line is useful for studying the differentiation and maturation of megakaryocyts. | ||
human | hemo-lymphocytic | JCRB1404 | Minami-1 | follicular B cell lymphoma | ||
human | hemo-lymphocytic | JCRB1405 | Minami-2 | B cell lymphoma (Burkitt type) | ||
human | hemo-lymphocytic | JCRB1325 | MKPL-1 | A megakaryoblastic leukemia cell line from human acute myeloblastic leukemia. | ||
human | hemo-lymphocytic | JCRB0146 | MLMA | The cells are IgD, IgM positive, hairy B-cells from human malignant lymphoma patient. | ||
human | hemo-lymphocytic | JCRB9048 | MOLT-3 | leukemia, acute lymphoblastic | ||
human | hemo-lymphocytic | JCRB9031 | MOLT-4 | leukemia, acute T lymphoblastic | ||
human | hemo-lymphocytic | IFO50362 | MOLT-4 | leukemia, acute T lymphoblastic | ||
human | hemo-lymphocytic | JCRB0021 | MOLT-4F | leukemia, acute T lymphoblastic | ||
human | hemo-lymphocytic | IFO50513 | MTA | leukemia, NK-like T cell line | ||
human | hemo-lymphocytic | JCRB0158.0 | MY | Human bone marrow mononuclear cells derived from a patient having acute biphenotypic leukemia. | ||
human | hemo-lymphocytic | JCRB0158.1 | MY-M12 | Subclone of the MY, human bone marrow mononuclear cells. | ||
human | hemo-lymphocytic | JCRB0158.2 | MY-M13 | Subclone of the MY cells, human bone marrow mononulcear cells. | ||
human | hemo-lymphocytic | IFO50479 | NAGL-1 | The CDR III of this line has been sequenced. | ||
human | hemo-lymphocytic | JCRB1332 | NALL-1 | Human 'null' cell from ALL cell line. | ||
human | hemo-lymphocytic | JCRB1475 | Nalm-6-MSH+ | Human cell line derived from B cell leukemia. (MSH+, POL(WT), TK+/-) | ||
human | hemo-lymphocytic | IFO50040 | Namalwa | This cell line produce interferon. | ||
human | hemo-lymphocytic | IFO50039 | NC-37 | lymphoblast, Contamination of Raji cells has been suspected. | ||
human | hemo-lymphocytic | IFO50525 | NCO2 | Human myelogenous leukemia cell line. | ||
human | hemo-lymphocytic | IFO50476 | NKM-1 | leukemia, acute myeloid, myeloid leukemia cells, responsive to G-CSF and M-CSF for growth | ||
human | hemo-lymphocytic | IFO50474 | NOMO-1 | This cell line is useful for studying the differentiation and maturation of monocytes. | ||
human | hemo-lymphocytic | JCRB1069 | NOMO-1/ADM | leukemia, acute monocytic, adriamycin-resistant derivative of NOMO-1 | ||
human | hemo-lymphocytic | IFO50475 | NOMO-1s | This cell line is useful for studying the differentiation and maturation of monocytes. | ||
human | hemo-lymphocytic | JCRB0095 | P32/ISH | lymphoma, Burkitt's | ||
human | hemo-lymphocytic | JCRB1345 | PALL-2 | Ph1 chromosome-positive human acute lymphoblastic leukemia cell line. | ||
human | hemo-lymphocytic | JCRB0830 | PEER | Human lymphoid cell line from a case of T-leukemia lacks some typical cell surface properties of T cells. | ||
human | hemo-lymphocytic | JCRB9012 | RAJI | lymphoma, Burkitt's | ||
human | hemo-lymphocytic | IFO50046 | Raji | lymphoma, Burkitt's | ||
human | hemo-lymphocytic | JCRB9119 | Ramos(RA1) | lymphoma, Burkitt's (EBV negative) | ||
human | hemo-lymphocytic | JCRB1334 | RC-K8 | A human lymphoma cell line with t(11;14) chromosome abnormality. | ||
human | hemo-lymphocytic | JCRB0035 | RPMI 1788 | established from normal blood, IgM secreting | ||
human | hemo-lymphocytic | IFO50037 | RPMI 1788 | established from normal blood, IgM secreting | ||
human | hemo-lymphocytic | JCRB0034 | RPMI 8226 | myeloma, multiple | ||
human | hemo-lymphocytic | IFO50013 | RPMI 8226 | Ig lambda light chain-secreting. | ||
human | hemo-lymphocytic | JCRB0115 | SCC-3 | Human monocytic cell line expressing Interleukin-2 receptor. | ||
human | hemo-lymphocytic | JCRB1170 | SKNO-1 | a GM-CSF dependent cell line with an t8,21 chromosome translocation estabulished from a patient attacked by acute myeloid leukemia(AML) | ||
human | hemo-lymphocytic | JCRB0159 | SLVL | Human villous lymphoma B-cell line from splenic B-cell lymphoma. | ||
human | hemo-lymphocytic | JCRB1384 | STR-428 | Human HHV-8 negative malignant effusion lymphoma (DLBCL). | ||
human | hemo-lymphocytic | JCRB0112 | THP-1 | Human acute monocytic leukemia. | ||
human | hemo-lymphocytic | JCRB0112.1 | THP-1 | Human acute monocytic leukemia. | ||
human | hemo-lymphocytic | JCRB0157 | TK | Human B-cell lymphoma cell line with near-triploid chromosomes with t(14;18) and p53 gene point mutation. | ||
human | hemo-lymphocytic | JCRB1206 | TK | Brain lymphoma cell line. | ||
human | hemo-lymphocytic | IFO50516 | TMD5 | leukemia, acute B lymphoblastic, double Philadelphia chromosomes | ||
human | hemo-lymphocytic | IFO50038 | U-937 | lymphoma, diffuse histiocytic, monocyte-like characteristics | ||
human | hemo-lymphocytic | JCRB9021 | U937 | lymphoma, diffuse histiocytic, monocyte-like characteristics | ||
human | hemo-lymphocytic | JCRB0116.1 | U937 cl1-14 | lymphoma, histiocytic, highly susceptible clone of U937 for HIV | ||
human | hemo-lymphocytic | JCRB0116.2 | U937 cl1-22 | lymphoma, histiocytic, low susceptible clone of U937 for HIV | ||
human:hepatoblastoma Top | ||||||
human | hepatoblastoma | JCRB0401 | HUH-6 Clone 5 | Human hepatoblastoma cell line from an infant. | ||
human:intestine Top | ||||||
human | intestine | JCRB9076 | FHs 74 Int | Human fetal small intestin cells. | ||
human:kidney Top | ||||||
human | kidney | JCRB9068 | 293 | transformed embryonal kidney by adenovirus (type5) | ||
human | kidney | JCRB0801 | Caki-1 | renal clear cell carcinoma | ||
human | kidney | JCRB9065 | G-401 | Rhabdoid tumor of kidney (formerly classified as Wilms' tumor) | ||
human | kidney | JCRB9070 | G-402 | renal leiomyoblastoma | ||
human | kidney | JCRB1484 | JMU-RTK-2 | Malignant rhabdoid tumor of the kidney cell line. | ||
human | kidney | JCRB1150 | KMPC-3 | Human renal pelvis. | ||
human | kidney | JCRB1010 | KMRC-1 | Human tumor cell line from kidney. Clear cell renal carcinoma cell line. | ||
human | kidney | JCRB1011 | KMRC-2 | Human tumor cell line from kidney. Clear cell renal carcinoma cell line. | ||
human | kidney | JCRB1071 | KMRC-20 | Human renal carcinoma cell line from kidney. | ||
human | kidney | JCRB1012 | KMRC-3 | Human tumor cell line from kidney. Clear cell renal carcinoma cell line. The growth is extremely slow. | ||
human | kidney | JCRB1014 | KMRM-M1 | Human renal cancer cell line metastasized to muscle. | ||
human | kidney | JCRB0813 | VMRC-RCW | renal cell carcinoma | ||
human | kidney | JCRB0827 | VMRC-RCZ | renal carcinoma | ||
human:leukemia Top | ||||||
human | leukemia | JCRB1800 | BALM-23 | B cell leukemia cell line, ALL-L2 cell line, hypercalcemia | ||
human | leukemia | JCRB1843 | BALM-24 | B cell leukemia cell line, ALL-L3 cell line, t(8;14)(q24.1;q32) | ||
human | leukemia | JCRB1782 | BALM-7 | B cell leukemia cell line | ||
human | leukemia | JCRB1785 | BALM-9 | B cell leukemia cell line | ||
human | leukemia | JCRB0032 | CCRF-SB | leukemia, acute B lymphoblastic | ||
human | leukemia | JCRB1846 | EEB | Human cell line derived from erythroblastic leukemia. | ||
human | leukemia | JCRB1395 | Kasumi-2 | B cell precursor leukemia | ||
human | leukemia | JCRB1004 | Kasumi-3 | A novel human leukemia cell line established from blast cells of a patient attaked by myeloperoxidase-negative acute leukemia. | ||
human | leukemia | JCRB1024 | Kasumi-6 | Human acute myeloid leukemia cell line with dominant negative mutation in the C/EBP alpha gene. | ||
human | leukemia | JCRB0156 | KHYG-1 | Human natural killer cell line with a p53 point mutation as a model for p53-associated leukemogenesis and a model for differentiation of NK/T cells. | ||
human | leukemia | JCRB1810 | MOLM-13 | Human acute monocytic leukemia (AML-M5a) cell line. MOLM-13 was established from the same donor as MOLM-14. | ||
human | leukemia | JCRB1812 | MOLM-14 | Human acute monocytic leukemia (AML-M5a) cell line. MOLM-14 was established from the same donor as MOLM-13. | ||
human | leukemia | JCRB1815 | MOLM-16 | Megakaryoblastic leukemia cell line derived from minimally differentiated acute leukemia (AML-M0) with myeloid/NK precursor phenotype. | ||
human | leukemia | JCRB1807 | MOLM-6 | Human multiple leukemia cell line with diverse myeloid and/or megakaryoblastic characteristics | ||
human | leukemia | JCRB1822 | NALM-19 | Biphenotypic (B-cell and myeloid cell features) leukemic cell line. | ||
human | leukemia | JCRB1823 | NALM-20 | Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive leukemic cell line. | ||
human | leukemia | JCRB1825 | NALM-21 | Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive leukemic cell line. Recurrence of the same patient as NALM-20. | ||
human | leukemia | JCRB1826 | NALM-24 | Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive acute lymphoblastic leukemia cell line. From the same patient as NALM-25 | ||
human | leukemia | JCRB1828 | NALM-25 | Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive acute lymphoblastic leukemia cell line. Derived from the same patient as NALM-24 | ||
human | leukemia | JCRB1854 | NALM-29 | Biphenotypic (B-cell and myeloid cell features) t(9;22)(q34;q11)-positive B-cell precursor cell line establish from acute leukemia patient. | ||
human | leukemia | JCRB1858 | NALM-30 | Biphenotypic features carrying myeloperoxidase mRNA and protein with complex Philadelphia (Ph) chromosome, t(9;22;10)(q34;q11;q22), cell line establish from acute leukemia patient. Derived from the same patient as NALM-27, NALM-28, NALM-31, NALM-32. | ||
human | leukemia | JCRB1856 | NALM-37 | B-cell precurrsor (BCP) acute lymphoblastic leukemia (ALL) cell line. Derived from the same patient as NALM-36 | ||
human | leukemia | JCRB0094 | P30/OHK | leukemia, acute non T non B lymphoblastic | ||
human | leukemia | JCRB0091 | P31/FUJ | leukemia, acute monocytic | ||
human | leukemia | JCRB1319 | PL-21 | Human myeloid cell line derived from an acute promyelocytic leukemia. | ||
human | leukemia | JCRB0118 | SKM-1 | myelo dysplastic syndrome | ||
human | leukemia | JCRB0086 | TALL-1 | leukemia, acute T lymphoblastic | ||
human:liver cancer Top | ||||||
human | liver cancer | JCRB0403 | HuH-7 | Well differentiated human hepato cellular carcinoma cell line. | ||
human:liver, gallbladder Top | ||||||
human | liver, gallbladder | IFO50069 | Alexander cells | hepatoma, HBs antigen-positive. This cell line is the same cell line as PLF/PRF/5 (other name of PLC/PRF/5). | ||
human | liver, gallbladder | JCRB1054 | Hep G2 | Hepatoblastoma-derived (previously thought to be hepatocellular carcinoma-derived) cell line. | ||
human | liver, gallbladder | JCRB0404 | HLE | hepatoma, non-differentiated | ||
human | liver, gallbladder | JCRB0405 | HLF | hepatoma, non-differentiated | ||
human | liver, gallbladder | JCRB0425 | HuCCT1 | Human liver bile duct carcinoma cell line. | ||
human | liver, gallbladder | JCRB0199 | huH-1 | Human hepatoma cell line. | ||
human | liver, gallbladder | JCRB0426 | HuH28 | Human liver, bile duct carcinoma cell line. | ||
human | liver, gallbladder | JCRB1028 | JHH-2 | Human hepatocellular carcinoma cell line (Ed.II). | ||
human | liver, gallbladder | JCRB0435 | JHH-4 | Human hepatocellular carcinoma cell line. | ||
human | liver, gallbladder | JCRB1029 | JHH-5 | Human hepatocellular carcinoma (Ed.I) established from small liver cancer. | ||
human | liver, gallbladder | JCRB1030 | JHH-6 | Human hepatocellular carcinoma cell line. | ||
human | liver, gallbladder | JCRB1031 | JHH-7 | HBV integrated human hepato cellular carcinoma cell line. | ||
human | liver, gallbladder | JCRB1551 | KKU-055 | Human poorly differentiated cholangiocarcinoma cell line established from biliary tract. | ||
human | liver, gallbladder | JCRB1568 | KKU-100 | Human poorly differentiated cholangiocarcinoma cell line established from biliary tract. | ||
human | liver, gallbladder | JCRB1557 | KKU-213 | Human mixed (papillary and non-papillary) cholangiocarcinoma cell line established from biliary tract. | ||
human | liver, gallbladder | JCRB1772 | KKU-452 | Human poorly differentiated cholangiocarcinoma cell line established from biliary tract. | ||
human | liver, gallbladder | JCRB0160 | LI90 | Ito (fat-storing) cells, stellate-shaped mesenchymal cells that exist in the space of Disse of the liver and contain many fat droplets in cytoplasm. | ||
human | liver, gallbladder | JCRB1033 | NOZ | Human gallbladder carcinoma cell line. | ||
human | liver, gallbladder | JCRB0191 | OCUG-1 | Human gall bladder carcinoma cell line producing TA-4 antigen. | ||
human | liver, gallbladder | JCRB1032 | OZ | Human bile duct cell line established from ascites of the tumor patient who had differentiated adenocarcinoma. | ||
human | liver, gallbladder | JCRB0406 | PLC/PRF/5 | hepatoma, HBs antigen-positive | ||
Japan Domestic use only | human | liver, gallbladder | JCRB1501 | TYBDC-1 | Human bile duct cancer cell line. | |
Japan Domestic use only | human | liver, gallbladder | JCRB1499 | TYGBK-1 | Human gall bladder cancer cell line. | |
Japan Domestic use only | human | liver, gallbladder | JCRB1590 | TYGBK-8 | Human gall bladder cancer cell line. | |
human:lung Top | ||||||
human | lung | JCRB0815 | ABC-1 | adenocarcinoma | ||
human | lung | JCRB9101 | CCD-14Br | bronchus, diploid | ||
human | lung | JCRB0820 | EBC-1 | squamous cell carcinoma | ||
human | lung | IFO50089 | Flow2000 | Normal diploid fibroblasts with limited life span. | ||
human | lung | JCRB1080.0 | HARA | Human lung squamous cell carcinoma with PTHrP expression. | ||
human | lung | IFO50074 | HFL1 | Normal diploid fibroblasts with limited life span. | ||
human | lung | JCRB9054 | IMR-90 | Normal human fibroblast. | ||
human | lung | JCRB0519 | IMR-90-40 | Normal human fibroblast. | ||
human | lung | JCRB0235 | Lu-134-A-H | small cell carcinoma, classic type | ||
human | lung | JCRB0080 | LU99 | giant cell carcinoma | ||
human | lung | JCRB9008 | MRC-5 | fetal lung, normal diploid fibroblast | ||
human | lung | IFO50073 | MRC-5 | Normal diploid fibroblasts with limited life span (crisis PDL = 42-46). | ||
human | lung | JCRB0521 | MRC-5-30 | fetal lung, normal diploid fibroblast, PDL=about 30 | ||
human | lung | JCRB9060 | MRC-9 | fetal lung, normal diploid fibroblast | ||
human | lung | IFO50072 | MRC-9 | Normal diploid fibroblasts with limited life span (crisis PDL = 44). | ||
human | lung | JCRB1034 | OUS-11 | Normal human cell line from lung cancer patient. | ||
human | lung | JCRB1021 | RERF-LC-Ad2 | Human cancer cell line, adenocarcinoma. | ||
human | lung | JCRB0081 | RERF-LC-MS | adenocarcinoma | ||
human | lung | JCRB0818 | SBC-3 | small cell carcinoma, oat cell type | ||
human | lung | JCRB0819 | SBC-5 | small cell carcinoma, intermediate | ||
human | lung | JCRB0506.1 | SVts-8 | Human normal diploid fibroblast cell line transformed with SV40(ts) early gene. Cell culture at 34 C. | ||
human | lung | JCRB0501 | TIG-1-20 | fetal lung, normal diploid fibroblast, TIG-1, PDL=about 20 | ||
human | lung | JCRB0502 | TIG-1-30 | fetal lung, normal diploid fibroblast, TIG-1, PDL=about 30 | ||
human | lung | JCRB0503 | TIG-1-40 | fetal lung, normal diploid fibroblast, TIG-1, PDL=about 40 | ||
human | lung | JCRB0504 | TIG-1-50 | fetal lung, normal diploid fibroblast, TIG-1, PDL=about 50 | ||
human | lung | JCRB0505 | TIG-1-60 | fetal lung, normal diploid fibroblast, TIG-1, PDL=about 60 | ||
human | lung | JCRB0506 | TIG-3-20 | Normal fibroblast cell line derived from Japanese fetal lung. | ||
human | lung | JCRB0511 | TIG-7-20 | fetal lung, normal diploid fibroblast, TIG-7, PDL=about 20 | ||
human | lung | JCRB0103 | VMRC-LCP | squamous cell carcinoma | ||
human | lung | JCRB9042 | WI-26 VA4 | SV-40 virus transformed human lung cell line. | ||
human | lung | IFO50075 | WI-38 | Normal diploid fibroblast with limeted life span. This cell line at around 30 PDL is distributed. | ||
human | lung | JCRB9057 | WI-38 VA13 sub 2 RA | fetal lung, SV40 virus transformed, derivative of WI-38 | ||
human | lung | JCRB0518 | WI-38-40 | Normal primary cells from lung as well as JCRB0517. Now only the JCRB0518 with PDL 40 is available. | ||
human:lung (cancer) Top | ||||||
human | lung (cancer) | JCRB0076 | A549 | Human adeno carcinoma cell line derived from lung cancer. | ||
human | lung (cancer) | IFO50153 | A549 | adenocarcinoma | ||
human | lung (cancer) | JCRB1080.1 | HARA-B | HARA cell (human lung squamouse cell carcinoma) established from bone metastasis in nude mouse. | ||
human | lung (cancer) | JCRB1552 | HARA-B4 | HARA cell (human lung squamouse cell carcinoma) established from bone metastasis (4 times selection) in nude mouse. | ||
human | lung (cancer) | JCRB0138 | KHM-3S | small cell carcinoma, HTLV-1gene integration | ||
human | lung (cancer) | IFO50358 | KNS-62 | bronchial squamous carcinoma, metastasis to brain | ||
human | lung (cancer) | JCRB0258 | LC-1 sq | squamous cell carcinoma | ||
human | lung (cancer) | JCRB0169 | Lu-134-B | Small cell lung carcinoma cell line established through heterotransplanted tumor. | ||
human | lung (cancer) | JCRB0079 | LU65 | Human cell line with giant cell carcinoma of lung. | ||
human | lung (cancer) | JCRB0054 | LU65A | giant cell carcinoma | ||
human | lung (cancer) | JCRB0055 | LU65B | giant cell carcinoma | ||
human | lung (cancer) | JCRB0056 | LU65C | giant cell carcinoma | ||
human | lung (cancer) | JCRB0044 | LU99A | giant cell carcinoma | ||
human | lung (cancer) | JCRB0057 | LU99B | Lung giant cell carcinoma | ||
human | lung (cancer) | JCRB0058 | LU99C | Lung giant cell carcinoma. | ||
human | lung (cancer) | JCRB1081 | MS-1-L | Human lung small cell carcinoma from pleural effusion. | ||
human | lung (cancer) | JCRB1343 | OKa-C-1 | Lung cancer cell line producing both G-CSF and PTHrP. | ||
human | lung (cancer) | JCRB0077 | PC-3 | adenocarcinoma, intermediately differentiated | ||
human | lung (cancer) | JCRB1020 | RERF-LC-Ad1 | Human lung cancer cell line, adenocarcinoma. | ||
human | lung (cancer) | JCRB0102 | RERF-LC-FM | small cell carcinoma, intermediate | ||
human | lung (cancer) | JCRB0137 | RERF-LC-KJ | adenocarcinoma, transplantable to SCID mice and frequently metastasize to lymph nodes | ||
human | lung (cancer) | JCRB1019 | RERF-LC-Sq1 | Cell line established from human lung carcinoma tissue. | ||
human | lung (cancer) | JCRB1053 | STC 1 | Human small cell lung carcinoma. | ||
human | lung (cancer) | JCRB0814 | VMRC-LCD | adenocarcinoma | ||
human:lung cancer Top | ||||||
human | lung cancer | JCRB0829 | LK-2 | squamous cell carcinoma | ||
human | lung cancer | JCRB0170 | Lu-135 | Human small cell lung carcinoma cell line. | ||
human:lymph node Top | ||||||
Japan Domestic use only | human | lymph node | JCRB1470 | SUm/c | SUm/c was established from floating in the lymph of the thoracic duct of patients with esophageal squamous cell carcinoma. | |
human:lymphoblastoid Top | ||||||
human | lymphoblastoid | JCRB1752 | XYFMGG16M | EBV transformed B-cell lymphoblastoid cell line from human XY female. | ||
human:lymphocyte Top | ||||||
human | lymphocyte | JCRB9063 | WIL2-NS | B lymphocyte line, from patient with hereditary spherocytic anemia, non-immunoglobulin secreting variant | ||
human:lymphocytic Top | ||||||
human | lymphocytic | IFO50518 | KAI3 | EBV-infected NK-like cell line, IL-2 dependent | ||
human:lymphoma Top | ||||||
human | lymphoma | JCRB0101 | A3/KAW | lymphoma, malignant | ||
human | lymphoma | JCRB1765 | Akata-EBV-N | Epstein-Barr virus (EBV)-negative cell line established from a Japanese patient with Burkitt’s lymphoma. | ||
human | lymphoma | JCRB9071 | Daudi | lymphoma, Burkitt's | ||
human | lymphoma | JCRB1977 | HCF-MLp-N | human B-cell line derived from non-Hodgkin's lymphoma, Primary Central Nervous System Lymphoma, PCNSL | ||
human | lymphoma | JCRB1347 | KML-1 | Human B-cell lymphoma cell line. | ||
human | lymphoma | JCRB4016 | WILL3 | Human diffuse large B-cell lymphoma cell line with two translocations t(14;18)(q32; q21) and t(8;22)(q24;q11). | ||
human:mammary Top | ||||||
human | mammary | JCRB0166 | HMC-1-8 | A target cell of the T-cell killer clone T(cHMC-1). | ||
human | mammary | JCRB0134 | MCF-7 | Human metastatic mammary carcinoma cell line. | ||
human | mammary | JCRB0628 | MRK-nu-1 | Human mammary carcinoma cell line. | ||
human | mammary | JCRB0823 | YMB-1 | breast cancer, exhibit the same DNA profile as other breast carcinoma cell line ZR-75-1. | ||
human | mammary | JCRB0825 | YMB-1-E | breast cancer, exhibit the same DNA profile as other breast carcinoma cell line ZR-75-1. | ||
human:melanoma Top | ||||||
human | melanoma | IFO50276 | A2058 | malignant melanoma, metastasis to lymph node | ||
human | melanoma | JCRB0227 | C32TG | Human 6TG resistant amelanotic melanoma cell line from skin. | ||
human | melanoma | JCRB9074 | G-361 | malignant melanoma, skin | ||
human | melanoma | IFO50009 | G-361 | This cell line produces melanin. | ||
human | melanoma | IFO50321 | GAK | Human malignant melanoma cell line with the production of 5-S-cysteinyldopa. | ||
human | melanoma | JCRB0180 | GAK | Human malignant melanoma cell line with the production of 5-S-cysteinyldopa. | ||
human | melanoma | JCRB1018 | HMY-1 | Mlignant melanoma cell line. | ||
human | melanoma | JCRB0066 | Mewo | malignant melanoma | ||
human | melanoma | JCRB1041 | SEKI | Human malignant melanoma cell line. | ||
human | melanoma | JCRB0074 | VMRC-MELG | malignant melanoma, colon | ||
human:mesenchymal stem Top | ||||||
human | mesenchymal stem | JCRB1154 | UE7T-13 | Human bone marrow-derived mesenchymal stem cells. | ||
human:mesenchymal stem cell Top | ||||||
human | mesenchymal stem cell | JCRB1159 | UBE6T-15 | Human bone marrow-derived mesenchymal stem cells. | ||
human | mesenchymal stem cell | JCRB1140 | UBE6T-6 | Human bone marrow-derived mesenchymal stem cells. | ||
human | mesenchymal stem cell | JCRB1143 | UBE6T-7 | Human bone marrow-derived mesenchymal stem cells. | ||
Japan Domestic use only | human | mesenchymal stem cell | JCRB1108 | UCB408E6E7-31 | Human umbilical cord blood-derived mesenchymal stem cells. Not immortalized cell line (limited life span). | |
human | mesenchymal stem cell | JCRB1110 | UCB408E6E7TERT-33 | Human umbilical cord blood-derived mesenchymal stem cells. | ||
Japan Domestic use only | human | mesenchymal stem cell | JCRB1109 | UCB408E7-32 | Human umbilical cord blood-derived mesenchymal stem cells. Not immortalized cell line (limited life span) | |
human | mesenchymal stem cell | JCRB1107 | UCBTERT-21 | Human umbilical cord blood-derived mesenchymal stem cells. | ||
Japan Domestic use only | human | mesenchymal stem cell | JCRB1160 | UE6E7-16 | Human bone marrow-derived mesenchymal stem cells. Not immortalized cell line (limited life span). | |
human | mesenchymal stem cell | JCRB1149 | UE6E7T-11 | Human bone marrow-derived mesenchymal stem cells. | ||
human | mesenchymal stem cell | JCRB1151 | UE6E7T-12 | Human bone marrow-derived mesenchymal stem cells. | ||
human | mesenchymal stem cell | JCRB1133 | UE6E7T-2 | Human bone marrow-derived mesenchymal stem cells. | ||
human | mesenchymal stem cell | JCRB1147 | UE7T-9 | Human bone marrow-derived mesenchymal stem cells. | ||
human:muscular system Top | ||||||
human | muscular system | JCRB0525 | TIG-2M-30 | muscular tissue derived normal diploid fibroblast (not myoblast), PDL=about 30 | ||
human:myeloma Top | ||||||
human | myeloma | JCRB0133 | KHM-1B | myeloma, multiple, with hyperamylasemia. | ||
human | myeloma | JCRB1179 | KMS-11 | human myeloma cell line. | ||
human | myeloma | JCRB1642 | KMS-11/BTZ | bortezomib-resistant multiple myeloma cell line. | ||
human | myeloma | JCRB0429 | KMS-12-BM | myeloma, late stage of B-cell differentiation | ||
human | myeloma | JCRB0430 | KMS-12-PE | myeloma, late stage of B-cell differentiation | ||
human | myeloma | JCRB1196 | KMS-20 | human myeloma cell line. | ||
human | myeloma | JCRB1185 | KMS-21BM | human myeloma cell line. | ||
human | myeloma | JCRB1187 | KMS-26 | human myeloma cell line. | ||
human | myeloma | JCRB1188 | KMS-27 | human myeloma cell line. | ||
human | myeloma | JCRB1192 | KMS-28BM | human myeloma cell line. | ||
human | myeloma | JCRB1191 | KMS-28PE | Human myeloma cell line. | ||
human | myeloma | JCRB1391 | KMS-33 | human myeloma cell line. | ||
human | myeloma | JCRB1195 | KMS-34 | human myeloma cell line. | ||
human | myeloma | JCRB4021 | KMS21 | human myeloma cell line. Deposited as a set with KMS21R and KMS21RF | ||
human | myeloma | JCRB1820 | MOLP-2 | Multiple myeloma-derived cell line. IL-6 receptor(+), CD28(+), CD33(+), IgD ramda(+) (Growth is extremely slow, DT = 1 week.) | ||
human:nasal septum Top | ||||||
human | nasal septum | JCRB9058 | RPMI 2650 | quasi-diploid squamous carcinoma | ||
human:neural Top | ||||||
human | neural | JCRB0228 | A-172 | glioblastoma | ||
human | neural | IFO50361 | B2-17 | astrocytoma, thymidine kinase-deficient mutant of U-251 MG cells | ||
human | neural | IFO50289 | Becker | astrocytoma, GFAP-negative | ||
human | neural | JCRB0068 | Flow3000 | normal fibroblast | ||
human | neural | IFO50489 | GB-1 | glioma, GFAP, vimentin and fibronectin-positive | ||
human | neural | JCRB0612 | GOTO | neuroblastoma, adrenal gland | ||
human | neural | JCRB9050 | IMR-32 | Human neuroblastoma cell line. | ||
human | neural | IFO50283 | IMR-32 | Human nueroblastoma cell line. | ||
human | neural | IFO50434 | KALS-1 | GFAP is weakly positive. | ||
human | neural | JCRB0236 | KG-1-C | mixed glioma, GFAP-negative, S-100-positive (growth is very slow). | ||
human | neural | IFO50435 | KINGS-1 | astrocytoma, anaplastic, S-100, vimentin, CD13 and HNK-1-positive, weakly GFAP positive. | ||
human | neural | IFO50357 | KNS-60 | glioma, GFAP, S-100 and NSE-negative | ||
human | neural | IFO50359 | KNS-81 | glioma, GFAP and S-100-positive, NSE-negative | ||
human | neural | IFO50444 | KNS-81-FD | GFAP-positive human glioma cell line. | ||
human | neural | IFO50432 | KP-N-RT-BM-1 | neuroblastoma, from bone marrow, neuronal and Schwannian differentiation | ||
human | neural | IFO50433 | KP-N-SI9s | Alpha-smooth muscle actin and desmin-positive. Some S-type cells may have the potential to differentiate into cells with smooth muscle phonotypes. | ||
human | neural | IFO50431 | KP-N-YN | Alpha smooth muscle actin-positive. | ||
human | neural | IFO50436 | KS-1 | glioblastoma | ||
human | neural | JCRB0154 | NB(TU)1-10 | Humn neuroblastoma(stageIII) cell line from abdominal tumor with N-myc aberration. | ||
human | neural | JCRB0621 | NB-1 | Human neuroblastoma cell line differentiate in vitro by cAMP. | ||
human | neural | IFO50295 | NB-1 | neuroblastoma | ||
human | neural | JCRB1305 | NCC-RbC-39 | Huaman retinoblastoma cell line. The growth is extremely slow. | ||
human | neural | JCRB1182 | NCC-RbC-51 | Human retinoblastoma cell line. The growth is very slow. | ||
human | neural | JCRB1200 | NCC-RbC-53 | Human retinoblastoma cell line. The growth is extremely slow. | ||
human | neural | JCRB1183 | NCC-RbC-54 | Human retinoblastoma cell line. The growth is extremely slow. | ||
human | neural | JCRB1212 | NCC-RbC-56 | Human retinoblastoma cell line. The growth is extremely slow. | ||
human | neural | JCRB1190 | NCC-RbC-57 | Human retinoblastoma cell line. | ||
human | neural | JCRB1326 | NCC-RbC-60 | Huaman retinoblastoma cell line. The growth is very slow. | ||
human | neural | JCRB1214 | NCC-RbC-67 | Human retinoblastoma cell line. The growth is extremely slow. | ||
human | neural | JCRB1221 | NCC-RbC-92 | Huaman retinoblastoma cell line. The growth is extremely slow. | ||
human | neural | JCRB1223 | NCC-RbC-T1 | Human retinoblastoma cell line. The growth is very slow. | ||
human | neural | JCRB0833 | NH-12 | neuroblastoma, adrenal gland | ||
human | neural | JCRB0832 | NH-6 | neuroblastoma, adrenal gland, opsomyoclonus, truncal ataxia | ||
human | neural | IFO50467 | NMC-G1 | glioma, FGF-9-producing | ||
human | neural | IFO50368 | no.10 | Human anaplastic glioma cell line derived from brain. | ||
human | neural | IFO50369 | no.11 | glioma, anaplastic, GFAP-positive | ||
human | neural | JCRB1566 | NP 2 | Human cell line derived from human glioma. | ||
human | neural | JCRB1567 | NP 3 | Human cell line derived from human glioma. | ||
human | neural | JCRB1608 | NP 8 | Human cell line derived from human glioma. | ||
human | neural | JCRB1606 | Onda 10 | Human cell line derived from human glioma. | ||
human | neural | JCRB1605 | Onda 11 | Human cell line derived from human glioma. | ||
human | neural | JCRB1575 | Onda 7 | Human cell line derived from human glioma. | ||
human | neural | JCRB1578 | Onda 8 | Human cell line derived from human glioma. | ||
human | neural | JCRB1576 | Onda 9 | Human cell line derived from human glioma. | ||
human | neural | JCRB1583 | Onda 9R | Human cell line derived from human recurred glioma. | ||
human | neural | JCRB1607 | Onda 9R-B12 | Human clonal cell line derived from human recurred glioma. | ||
human | neural | IFO50355 | ONS-76 | medulloblastoma | ||
human | neural | JCRB1340 | RS-2 | metastatic primitive neuroectodermal tumor cell line (derived from metastatic tumor). | ||
human | neural | JCRB0106 | SCCH-26 | Human neuroblastoma cell line. | ||
human | neural | IFO50286 | SF126 | glioblastoma multiforme, GFAP-negative | ||
human | neural | JCRB9041 | T98G | Human glioblastoma multiforma tumor. | ||
human | neural | IFO50303 | T98G | glioblastoma, multiforme | ||
human | neural | JCRB0139 | TASK1 | Human cell line with primitive neuroectodermal tumor (Askin's tumor). | ||
human | neural | JCRB0618 | TGW | neuroblastoma, adrenal gland | ||
human | neural | JCRB0618.1 | TGW.P3 | Serum free cell culture of the human neuroblastoma cell line, TGW. | ||
human | neural | IFO50288 | U-251 MG | astrocytoma, GFAP-positive | ||
human | neural | IFO50285 | U-251 MG (KO) | Subline of U-251 MG (IFO 50288) with epithelial morphology. | ||
human | neural | IFO50493 | YH-13 | glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-resistant | ||
human | neural | JCRB0746 | YKG-1 | glioblastoma | ||
human:neuroblastoma cell line Top | ||||||
human | neuroblastoma cell line | JCRB0612.1 | GOTO.P3 | Serum free cell culture of neuroblastoma cell line. | ||
human:oral Top | ||||||
human | oral | JCRB0625 | Ca9-22 | squamous carcinoma, gingiva | ||
human | oral | JCRB9095 | HEPM | embryonic palatal mesenchyme, limited life span | ||
human | oral | JCRB0831 | HO-1-N-1 | squamous carcinoma, buccal mucosa | ||
human | oral | JCRB1354 | HSC-3-M3 | Highly metastatic cell line to lymph node in human oral squamous cell carcinoma derived from the HSC-3. | ||
human | oral | JCRB9103 | KD | fibroblast, lip | ||
human | oral | JCRB0194 | KON | Human squamous carcinoma cell line from oral floor. | ||
human | oral | JCRB0126.1 | KOSC-2 cl3-43 | Human tumor cells derived from oral cancer at stage III. The cells were originally cross contaminated with mouse cells but the mouse cells were eliminated in the JCRB cell bank and the cl3-43 subclone ID was applied to the cell name. | ||
human | oral | JCRB0198 | OSC-19 | Human squamous cell carcinoma cell line from tongue tumor with serum free cell culture. | ||
human | oral | JCRB0197 | OSC-20 | Human squamous cell carcinoma cell line from tongue metastasized to neck lymph node(left), which was cultured with serum free condition. | ||
human | oral | JCRB0260 | SAS | squamous carcinoma, tongue | ||
human | oral | JCRB1027 | SAT | Human squamous cell carcinoma with non-metastatic cell line derived from oral cavity. | ||
human | oral | JCRB9118 | SCC-4 | squamous carcinoma, tongue | ||
human | oral | JCRB1039 | SKN-3 | Human oral squamous carcinoma established from xenotransplantation in mice. | ||
human:oral cancer Top | ||||||
human | oral cancer | JCRB0828 | HO-1-u-1 | squamous carcinoma, mouth floor | ||
human | oral cancer | JCRB0622 | HSC-2 | squamous carcinoma, mouth | ||
human | oral cancer | JCRB0624 | HSC-4 | Human squamous carcinoma cell line from tongue. | ||
human:ovarian cancer Top | ||||||
human | ovarian cancer | JCRB1729 | RMG-V | Human ovarian clear cell adenocarcinoma cell line. | ||
human:ovary Top | ||||||
human | ovary | JCRB1359 | HAC-2 | Human ovary cancer cell line derived from mesonephros. | ||
human | ovary | JCRB1539 | HAC-2 | Human ovary cancer cell line derived from mesonephros. | ||
human | ovary | JCRB0098 | KURAMOCHI | undifferentiated carcinoma, ascites | ||
human | ovary | JCRB0240 | MCAS | mucinous cystadenocarcinoma | ||
human | ovary | JCRB1308 | NCC-OvC-K119 | Huaman ovarian carcinoma cell line. | ||
human | ovary | JCRB1043 | OVISE | Human cell line derived from ovarian tumor. | ||
human | ovary | JCRB1044 | OVKATE | Human cell line derived from ovarian tumor. | ||
human | ovary | JCRB1045 | OVMANA | Human cell line derived from ovarian tumour. | ||
human | ovary | JCRB1049 | OVMIU | Human cell line derived from ovarian tumour. | ||
human | ovary | JCRB1050 | OVMIU-II | Human cell line derived from ovarian tumour. | ||
human | ovary | JCRB1046 | OVSAHO | Human cell line derived from ovarian tumour. | ||
human | ovary | JCRB1047 | OVSAYO | Human cell line derived from ovarian tumour. | ||
human | ovary | JCRB1048 | OVTOKO | Human cell line derived from ovarian tumour. | ||
human | ovary | IFO50317 | RKN | leiomyosarcoma | ||
human | ovary | JCRB0176 | RKN | Human tumor cell line from myoma ovarii. | ||
human | ovary | IFO50315 | RMG-I | clear cell carcinoma | ||
human | ovary | JCRB0172 | RMG-I | Human tumor cell line from ovarian mesonephroid adenocarcinoma. | ||
human | ovary | JCRB0172.1 | RMG-II | Human ovarian mesonephroid adenocarcinoma cell line. | ||
human | ovary | IFO50320 | RMUG-S | mucinous cystadenocarcinoma | ||
human | ovary | JCRB0234.0 | TYK-nu | undifferentiated carcinoma | ||
human | ovary | JCRB0234.1 | TYK-nu.CP-r | Human cell line derived from ovary with undifferentiated carcinoma. | ||
human:pancreas Top | ||||||
human | pancreas | JCRB4026 | KE-66 | Poorly differentiated adenocarcinoma with giant cells | ||
Japan Domestic use only | human | pancreas | JCRB1427 | KMP2 | Human moderately differentiated pancreatic adenocarcinoma cell line established from liver metastasis. | |
Japan Domestic use only | human | pancreas | JCRB1464 | KMP5 | Human moderately differentiated adenocarcinoma cell line established from liver metastasis. | |
Japan Domestic use only | human | pancreas | JCRB1429 | KMP7 | Human pancreatic adenocarcinoma cell line established from liver metastasis. | |
Japan Domestic use only | human | pancreas | JCRB1461 | KMP8 | Human moderately differentiated pancreatic adenocarcinoma cell line established from liver metastasis. | |
human | pancreas | JCRB0181 | KP-2 | Human pancreatic tumor cell line. | ||
human | pancreas | JCRB0178.0 | KP-3 | A metastasis of adenosquamous carcinoma of the human pancreatic duct. | ||
human | pancreas | JCRB0178.1 | KP-3L | Human tumor cell line obtained from metastasis of adenosquamous carcinoma of the pancreatic duct. | ||
human | pancreas | JCRB0182 | KP-4 | Human tumor cell line secreting parathyroid hormone-related peptide (PTHrP) established from pancreatic tumor. | ||
human | pancreas | JCRB0070 | MIA PaCa-2 | pancreatic cancer | ||
human | pancreas | JCRB0183 | QGP-1 | Carcinoembryonic antigen (CEA)-producing human pancreatic ilet cell carcinoma cell line. | ||
human | pancreas | JCRB1882 | Sui65 | Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from peritoneal metastasis. | ||
human | pancreas | JCRB1919 | Sui69 | Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from pancreas adenocarcinoma. (The life span of this cell line is limited.) | ||
human | pancreas | JCRB1931 | Sui74 | Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from pancreas adenocarcinoma. | ||
human | pancreas | JCRB1929 | Sui77 | Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from liver metastasis. | ||
human | pancreas | JCRB1094 | SUIT-2 | Human pancreatic cancer cell line established from liver metastasis. | ||
human | pancreas | JCRB1921 | TCC-Pan2 | Pancreatic ductal adenocarcinoma. Cell line established from ascites. | ||
Japan Domestic use only | human | pancreas | JCRB1500 | TYPK-1 | Human pancreas adenocarcinoma cell line. | |
human:placenta Top | ||||||
human | placenta | JCRB9111 | BeWo | Human placenta derived cell line. | ||
human:pleura Top | ||||||
human | pleura | JCRB1913 | Me1Tu | Transplanted cell line of malignant pleural mesothelioma TCC-MESO-1 into SCID mice. | ||
human | pleura | JCRB1930 | Me2Tu | Transplanted cell line of malignant pleural mesothelioma TCC-MESO-2 into SCID mice. | ||
human | pleura | JCRB1937 | Me3Tu | Transplanted cell line of malignant pleural mesothelioma TCC-MESO-3 into SCID mice. | ||
human | pleura | JCRB1894 | TCC-MESO-1 | Cell line of malignant pleural mesothelioma. TCC-MESO-2 established from same individual. | ||
human | pleura | JCRB1898 | TCC-MESO-2 | Cell line of malignant pleural mesothelioma. TCC-MESO-1 established from same individual. | ||
human | pleura | JCRB1909 | TCC-MESO-3 | Cell line of malignant pleural mesothelioma. | ||
human:prostate gland Top | ||||||
human | prostate gland | JCRB9110 | PC-3 | adenocarcinoma | ||
human:rectum Top | ||||||
human | rectum | JCRB0207 | CaR-1 | adenocarcinoma | ||
human | rectum | JCRB0256 | RCM-1 | adenocarcinoma, well differentiated | ||
human | rectum | JCRB9115 | SW837 | adenocarcinoma | ||
human | rectum | JCRB1986 | UCCA-24 | Derived from colorectal cancer with ulcerative colitis. Isolated as poorly differentiated adenocarcinoma by cloning. | ||
human | rectum | JCRB1997 | UCCA-25 | Derived from colorectal cancer with ulcerative colitis. Isolated as adenosquamous carcinoma of the adenomas by cloning. | ||
human:sarcoma Top | ||||||
human | sarcoma | IFO50107 | G-292 clone A141B1 | osteosarcoma | ||
human | sarcoma | IFO50106 | HOS | osteosarcoma | ||
human | sarcoma | JCRB9113 | HT-1080 | Human sarcoma cell line with activated N-ras oncogne. | ||
human | sarcoma | IFO50354 | HT-1080 | fibrosarcoma, acetabulum | ||
human | sarcoma | JCRB0413 | HuO-3N1 | osteosarcoma, ilium | ||
human | sarcoma | JCRB0427 | HuO9 | A cell line established from a human osteosarcoma transplanted into athymic nude mice after fifth passages. The cell line expressed 1,25(OH)2D3-responsive alikaline phosphatase and produced tumors in the dorsum of nude mice. | ||
human | sarcoma | JCRB0428 | HuO9N2 | osteosarcoma | ||
human | sarcoma | JCRB1648 | ICH-ERMS-1 | Human cell derived from anaplastic embryonal rhabdomyosarcoma. | ||
human | sarcoma | JCRB0200 | KMLS-1 | liposarcoma | ||
human | sarcoma | JCRB0627 | KYM-1 | Human rhabdomyosarcoma cell line derived from neck tumor. | ||
human | sarcoma | IFO50108 | MG-63 | osteosarcoma | ||
Japan Domestic use only | human | sarcoma | JCRB1507 | NMFH-1 | Human retroperitoneal tumor cell line. | |
human | sarcoma | JCRB0614 | NY | osteosarcoma, femur | ||
human | sarcoma | IFO50488 | OUMS-27 | chondrosarcoma, type 1 ,2 and 3 collagens; type 9 and 11 collagen mRNA; proteoglycan-producing | ||
human | sarcoma | JCRB1806 | PIS-1 | Human pulmonary intimal sarcoma | ||
human | sarcoma | JCRB9072 | RD | rhabdomyosarcoma | ||
human | sarcoma | JCRB0108 | SCCH-196 | Human small round cell sarcoma. | ||
Japan Domestic use only | human | sarcoma | JCRB1521 | TYLMS-1 | Human leiomyosarcoma cell lineestablised from retroperitopneal tumor. | |
human:skin Top | ||||||
human | skin | IFO50418 | ASF-4-1 | Normal diploid (46, XY) fibroblast with limited life span. The ASF-4-1 and the ASF-4-2 lines were established from skins of the same donor at different ages. This cell line was taken from the donor at 36 years and 2 month-old | ||
human | skin | IFO50419 | ASF-4-2 | Normal diploid (46, XY) fibroblast with limited life span. The ASF-4-1 and ASF-4-2 lines were established from skins of the same donor at different ages. This cell line was taken from the donor at 47 years and 6 month-old. | ||
human | skin | JCRB1431 | ASF-4-3L | Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages. | ||
human | skin | JCRB1441 | ASF-4-4L1 | Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages. | ||
human | skin | JCRB1442 | ASF-4-4L2 | Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages. | ||
human | skin | JCRB1705 | ASF-4-5L1 | Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3, ASF-4-4 and the ASF-4-5 lines were established from skins of the same donor at different ages. | ||
human | skin | JCRB1703 | ASF-4-5L2 | Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3, ASF-4-4 and the ASF-4-5 lines were established from skins of the same donor at different ages. | ||
human | skin | JCRB1709 | ASF-4-5R1 | Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3, ASF-4-4 and the ASF-4-5 lines were established from skins of the same donor at different ages. | ||
human | skin | JCRB9078 | De Gin | osteoporosis, skin | ||
human | skin | JCRB9104 | Detroit 510 | Human skin, galactosemia cell line. | ||
human | skin | JCRB9102 | Detroit 525 | Turner's syndrome, skin | ||
human | skin | JCRB9044 | Detroit 532 | Fibroblast line from Down's syndrome patient. | ||
human | skin | JCRB9045 | Detroit 539 | Down's syndrome, skin | ||
human | skin | IFO50079 | Flow7000 | Normal diploid fibroblasts with limited life span. | ||
human | skin | JCRB1008 | HFb16d | Normal human fibroblast cell line derived from foreskin which was transfected by the HPV16 DNA. No teromerase activity. | ||
human | skin | JCRB1017 | HKA-1 | A cell line derived from a keratoacanthoma of human skin, grow in a monolayer with anaplastic feature. | ||
human | skin | IFO50350 | Hs68 | Normal diploid fibroblasts with limited life span. | ||
human | skin | JCRB1015 | HSC-1 | A cell line of a squamous cell carcinoma of human skin. | ||
human | skin | JCRB1016 | HSC-5 | A cell line derived from human skin squamous cell carcinoma having anaplastic epithelioid features. | ||
human | skin | JCRB0072 | MiTen | Human cell line from Lesch-Nyhan syndrome. | ||
human | skin | JCRB0141 | PHK16-0b | Normal keratinocyte cells immortalized with HPV16 virus genome and the growth is dependent to EGF. More than 95% of cells are diploid. | ||
human | skin | JCRB1093 | PSVK1 | Human normal keratinocyte prepared from human foreskin that was immortalized by the infection of the pSV40 ori-(minus) DNA. | ||
human | skin | JCRB9079 | Ran Nor | osteoporosis, skin | ||
human | skin | JCRB0075 | SF-TY | normal fibroblast | ||
human | skin | JCRB0526 | TIG-101 | Normal human diploid cell from skin | ||
human | skin | JCRB0527 | TIG-102 | Normal human skin fibroblast cell line. | ||
human | skin | JCRB0528 | TIG-103 | skin, normal diploid fibroblast | ||
human | skin | JCRB0532 | TIG-107 | skin, normal diploid fibroblast | ||
human | skin | JCRB0537 | TIG-108 | skin, normal diploid fibroblast | ||
human | skin | JCRB0538 | TIG-109 | Normal diploid human skin cells. | ||
human | skin | JCRB0543 | TIG-110 | Normal diploid fibroblast from human skin with limited lifespan. | ||
human | skin | JCRB0541 | TIG-111 | Normal diploid fibroblast from human skin with limited lifespan. | ||
human | skin | JCRB0533 | TIG-112 | skin, normal diploid fibroblast | ||
human | skin | JCRB0539 | TIG-113 | Human normal fibroblast from skin. | ||
human | skin | JCRB0534 | TIG-114 | skin, normal diploid fibroblast | ||
human | skin | JCRB0535 | TIG-118 | skin, normal diploid fibroblast | ||
human | skin | JCRB0540 | TIG-119 | Normal human diploid cell from skin. | ||
human | skin | JCRB0542 | TIG-120 | Normal diploid fibroblast from human skin with limited lifespan. | ||
human | skin | JCRB0536 | TIG-121 | skin, normal diploid fibroblast | ||
human | skin | JCRB0544 | TIG-3S | Normal diploid fibroblast from human male skin with limited life span. | ||
human:stomach Top | ||||||
human | stomach | JCRB1886 | 39As8 | Peritoneal disseminated metastatic cell line established from signet ring cell gastric carcinoma (HSC-39). | ||
human | stomach | JCRB1950 | 85As2 | Peritoneal disseminated metastatic cell line established from gastric cancer cell line (MKN45cL85). Cachexia-inducing cell line. | ||
human | stomach | JCRB0061 | AZ-521 | Reported as Human gastric cancer cell line. The STR DNA analysis pattern of AZ-521 revealed to be identical to that of other cell line derived from human duodenum carcinoma, HuTu 80 in ATCC (registry number, HTB-40) | ||
human | stomach | JCRB1074 | FU97 | Human stomach cancer cell line with AFP production. | ||
human | stomach | JCRB1956 | HSC-39 PF | Cell line that can be cultured only with HamF12/DMEM (protein free). Culture start at thawing must with 2% FBS. | ||
human | stomach | JCRB1954 | HSC-39R10C | HSC-39-derivative. TGF-β resistant subclone mutated by MNU (N-Methyl-N-nitrosourea). | ||
human | stomach | JCRB1075.0 | IM95 | Human gastric cancer cell line. | ||
human | stomach | JCRB1075.1 | IM95m | Human gastric cancer cell line. | ||
human | stomach | JCRB0611 | KATOIII | signet ring cell carcinoma | ||
Human:stomach Top | ||||||
Human | stomach | JCRB1939 | MKN45cL85 | Subclone of MKN45 (Human Gastric Cancer) cell line. Cachexia-inducing cell line. | ||
human | stomach | JCRB1025 | MKN7 | tubular adenocarcinoma, well differentiated | ||
human | stomach | JCRB0255 | MKN74 | Human cell line derived from stomach cancer. | ||
human | stomach | JCRB1228 | NCC-StC-K140 | Human stomach carcinoma cell line. | ||
human | stomach | JCRB0821 | NUGC-2 | adenocarcinoma, poorly differentiated | ||
human | stomach | JCRB0822 | NUGC-3 | adenocarcinoma, poorly differentiated | ||
human | stomach | JCRB0834 | NUGC-4 | adenocarcinoma, poorly differentiated, signet ring cell carcinoma | ||
human | stomach | JCRB0192 | OCUM-1 | Human gastric cancer cell line from poorly differentiated adenocarcinoma. | ||
human | stomach | JCRB1009 | RERF-GC-1B | Human gastric cancer cell line established from a metastatic tissue of pyloric lymph nodes. | ||
human | stomach | JCRB0251 | SCH | choriocarcinoma arising at stomach from male patient | ||
human | stomach | JCRB1944 | SH101-P4 | Subclone of SH101 (Human Gastric Cancer) cell line. Well differenciated adenocarcinoma. | ||
human | stomach | JCRB0124 | Takigawa | gastric carcinoma, proliferates very slowly (D.T.=2 weeks). | ||
human | stomach | JCRB1941 | TU-KatoIII | Cell line isolated as 100% tumor-forming cells after tumor formation in immunodeficient mice (NOD Scid→Scid→nu/nu). | ||
Japan Domestic use only | human | stomach | JCRB1522 | YS-1 | Human primmary cell line established from stomach (tumor infiltrating fibroblast). | |
human:stomach cancer Top | ||||||
human | stomach cancer | JCRB1864 | HSC-39 | Human signet ring cell gastric carcinoma cell line establised in vitro from ascites. | ||
human | stomach cancer | JCRB0252 | MKN1 | adenosquamous carcinoma | ||
human | stomach cancer | JCRB0254 | MKN45 | adenocarcinoma, poorly differentiated | ||
human:teratocarcinoma Top | ||||||
human | teratocarcinoma | JCRB1005 | NCC-IT-A3 | Human teratocarcinoma cell line from anterior mediastinum. | ||
human | teratocarcinoma | JCRB9061 | PA-1 | Human ovarian teratocarcinoma. | ||
human | teratocarcinoma | JCRB1052 | PA-1/6TG-r | Human teratocarcinoma cell line PA-1 with 6TG resistance. | ||
human:testis Top | ||||||
human | testis | JCRB0613 | ITO-II | Human testicular tumor cell line. | ||
human | testis | JCRB1166 | NCR-G1 | Human yolk sac tumor (testicular tumor) | ||
human | testis | JCRB1167 | NCR-G2 | Complex type germ cell tumor of human testis origin. | ||
human | testis | JCRB1168 | NCR-G3 | Complex type germ cell tumor of human testis origin. | ||
human | testis | JCRB1175 | NCR-G4 | Complex type germ cell tumor of human testis origin. | ||
human | testis | JCRB0162 | NEC14 | testicular germ cell tumor | ||
human | testis | JCRB0250 | NEC8 | testicular germ cell tumor | ||
human:thymus Top | ||||||
human | thymus | JCRB1330 | Ty-82 | Thymic carcinoma cell line. | ||
human:thyroid Top | ||||||
human | thyroid | JCRB0824 | 8305C | Human undifferentiated thyroid carcinoma with C:G->T:A mutation at codon 273 of p53 gene. | ||
human | thyroid | JCRB0826 | 8505C | thyroid carcinoma, undifferentiated | ||
human | thyroid | JCRB1073 | ASH-3 | Tumor cell line with multidrug registance obtained from rapidly growing cervical tumor(neck) diagnosed as an anaplastic thyroid carcinoma. | ||
human | thyroid | JCRB0164 | HTC/C3 | Human thyroid carcinoma cell line. | ||
human | thyroid | JCRB1079 | IHH-4 | Human papillary thyroid carcinoma cell line metastased to lymphnode. STR-PCR analysis showed the same pattern with the cell line TMH-1. | ||
human | thyroid | JCRB0148 | KHM-5M | Undifferentiated human thyroid cell line producing interl eukin 8. | ||
human | thyroid | JCRB1066 | KMH-2 | Human anaplasitc thyroid carcinoma cell line with multidrug resistance, derived from a left cervical tumor with a sligt leukocytosis. | ||
human | thyroid | JCRB1891 | OCUT-1C | human anaplastic thyroid cancer cell line | ||
human | thyroid | JCRB1892 | OCUT-3 | human anaplastic thyroid cancer cell line | ||
human | thyroid | JCRB0239 | TCO-1 | non differentiated cancer | ||
human | thyroid | JCRB1078 | TMH-1 | Human adherent monolayer cell line with multidrug resistance obtained from a benign goiter and chronic thyroiditis. | ||
human:thyroid cancer Top | ||||||
human | thyroid cancer | JCRB1897 | OCUT-1F | human anaplastic thyroid cancer cell line | ||
human | thyroid cancer | JCRB1857 | OCUT-4 | human anaplastic thyroid cancer cell line | ||
human | thyroid cancer | JCRB1872 | OCUT-6 | human anaplastic thyroid cancer cell line | ||
human:tongue Top | ||||||
human | tongue | JCRB0623 | HSC-3 | Human oral squamous carcinoma cell line with high metastatic potential. | ||
human:uterine cervix Top | ||||||
human | uterine cervix | IFO50323 | BOKU | cervical squamous cell carcinoma | ||
human | uterine cervix | IFO50007 | Ca Ski | Human epidermoid cervical cancer cell line. | ||
human | uterine cervix | JCRB1153 | HCA-1 | Human endocervical adenocarcinoma cell line. | ||
human | uterine cervix | JCRB1203 | HCS-2 | Human squamous cell carcinoma from uterine cervix. | ||
human | uterine cervix | JCRB1205 | HCSC-1 | Human endocervical carcinoma cell line. | ||
human | uterine cervix | JCRB9004 | HeLa | The first aneuploid, epitherial-like cell line(Feb. 1951) from human tissue and maintained continuously by serial cell culture. | ||
human | uterine cervix | JCRB9086 | HeLa 229 | Subline of the HeLa cell. | ||
human | uterine cervix | JCRB0213 | HeLa AG | epitheloid carcinoma, 8-azaguanine-resistant | ||
human | uterine cervix | JCRB9010 | HeLa S3 | cervical epitheloid carcinoma, adaptable to a suspension culture | ||
human | uterine cervix | IFO50011 | HeLa S3 | This cell line is a clone derived from the HeLa cells. Adaptable to suspension culture. | ||
human | uterine cervix | JCRB0713 | HeLa S3 (sc) | HeLa derivative, can grow in suspension culture | ||
human | uterine cervix | JCRB0214 | HeLa TG | epitheloid carcinoma, 6-thioguanine-resistant | ||
human | uterine cervix | JCRB0215 | HeLa TG Cap | epitheloid carcinoma, 6-thioguanine, chloramphenicol-resistant | ||
human | uterine cervix | JCRB0649 | HeLa.P3 | Serum free cell line of the famous HeLa. | ||
human | uterine cervix | JCRB0606 | HeLa.P3(S) | HeLa cell derived, can grow in a serum-free medium | ||
human | uterine cervix | JCRB0810 | ME-180 | cervical carcinoama | ||
human | uterine cervix | JCRB0174.0 | NCC16-P11 | Normal human endo-cervical columner cells immortalized by HPV16 virus genome and no tumor formation observed in nude mice. Growth is not dependent to EGF. | ||
human | uterine cervix | JCRB1090 | NCE 16IIA | HPV16 transformed noraml cells derived from human cervix. | ||
human | uterine cervix | JCRB1092 | NCE SVIA6 | SV40 transformed human keratinocyte cell line. | ||
human | uterine cervix | JCRB1091 | NCE SVIIA3 | SV40 transformed keratinocyte cells derived from human cervix. | ||
human | uterine cervix | JCRB0140 | NCE16 | Normal ecto-cervical keratinocyte cells immortalized by HPV16 virus genome. Growth of this cell line is dependent to EGF. | ||
human | uterine cervix | IFO50308 | SKG-I | cervical epidermoid carcinoma | ||
human | uterine cervix | IFO50309 | SKG-II | cervical epidermoid carcinoma, large cell, non-keratinizing type | ||
human | uterine cervix | JCRB0232 | SKG-IIIa | cervical epidermoid carcinoma, clear cell type | ||
human | uterine cervix | IFO50310 | SKG-IIIa | cervical epidermoid carcinoma, clear cell type | ||
human | uterine cervix | IFO50311 | SKG-IIIb | cervical epidermoid carcinoma, large cell, non-keratinizing type | ||
human | uterine cervix | JCRB0232.1 | SKG-IIIb | Human tumor cell line with non-keratinizing type squamous cell carcinoma from cervical tumor. Temperature sensitive growth was observed. | ||
human:uterus Top | ||||||
human | uterus | JCRB1601 | EMTOKA | Human cell line derived from uterine carcinosarcoma. | ||
human | uterus | JCRB1201 | GCH-nu-YS | Human gestational choriocarcinoma cell line. | ||
human | uterus | JCRB0042 | HEC-1 | Human endometrial adenocarcimona cell line. (HEC-1-B). | ||
human | uterus | JCRB1117 | HEC-1-A | Human endometroid adenocarcinoma, G2 from Japanese female. | ||
human | uterus | JCRB1193 | HEC-1-B | Endometrioid adenocarcinoma (G2) from human uterus body. | ||
human | uterus | JCRB1123 | HEC-108 | Human tumor cell line from uterine endometrium. | ||
human | uterus | JCRB1124 | HEC-116 | Human tumor cell line from endometrioid adenocarcinoma G2. | ||
human | uterus | JCRB1122 | HEC-151 | Human endometrioid adenocarcinoma, G2. | ||
human | uterus | JCRB1141 | HEC-251 | Human endometrial carcinoma from uterus body. | ||
human | uterus | JCRB1142 | HEC-265 | Human endometrioid adenocarcinoma, G1 from uterus. | ||
human | uterus | JCRB1145 | HEC-50B | Human endometrioid adenocarcinoma (G3) from japanese patient. | ||
human | uterus | JCRB1120 | HEC-59 | Human tumor cell line from endometrioid adenocarcinoma G2. | ||
human | uterus | JCRB1118 | HEC-6 | Human endometrial adenocarcinoma cell line. | ||
human | uterus | JCRB1121 | HEC-88nu | endometrial adenocarcinoma | ||
human | uterus | IFO50322 | NJG | gestational uterine choriocarcinoma | ||
human | uterus | IFO50314 | SKN | leiomyosarcoma | ||
human | uterus | IFO50312 | SNG-II | endometrial adenocarcinoma | ||
human | uterus | IFO50313 | SNG-M | endometrial adenocarcinoma | ||
human | uterus | JCRB0179 | SNG-M | Intermedicately differentiated human adenocarcinoma cell line. | ||
human:uterus cancer Top | ||||||
human | uterus cancer | JCRB1505 | Ishikawa 3-H-12 | Estrogen receptor (ER), progesterone receptor (PR) expressing cell line. | ||
human | uterus cancer | JCRB0173 | SKN | Human tumor cell line from uterus leiomyosarcoma. | ||
human:vascular system Top | ||||||
human | vascular system | IFO50271 | HUV-EC-C | Normal endothelial cells with limited life span. For cultivation, endothelial cell growth supplement can be substituted by ca 10 ng/ml basic FGF. | ||
Japan Domestic use only | human | vascular system | JCRB1520 | TYHPC-1 | Human hemangiopericytoma cell line established from liver metastasis. | |
human chromosome-introduced:human monochromosomal hybrid panel Top | ||||||
human chromosome-introduced | human monochromosomal hybrid panel | JCRB2209 | CHO(His9) | contains human chromosome # 9 (MTA with Tottori Univ. is required.) | ||
Indian Muntjak:skin Top | ||||||
Indian Muntjak | skin | JCRB9100 | Indian Muntjac | Indian muntjak cell line, a primitive deer. | ||
Indian Muntjak:thymus Top | ||||||
Indian Muntjak | thymus | JCRB0609.1 | Mm2T.P3 | Mutntjac thymus cell cell line. | ||
Indian Muntjak | thymus | JCRB0650.1 | Mm2T12.P3 | Serum free subline from Mm2T cells. | ||
marsupial (potoroo, rat kangaroo):kidney Top | ||||||
marsupial (potoroo, rat kangaroo) | kidney | JCRB9039 | Pt K1 | kidney | ||
marsupial (potoroo, rat kangaroo) | kidney | JCRB0007 | Pt K2 | DNA replication study | ||
marsupial (potoroo, rat kangaroo) | kidney | IFO50012 | Pt K2 | kidney, epithelial-like | ||
marsupial (potoroo, rat kangaroo) | kidney | JCRB9052 | Pt K2 (NBL-5) | kidney | ||
mink:lung Top | ||||||
mink | lung | JCRB9128 | Mv 1 Lu | useful for focus forming assays of murine and feline sarcoma virus | ||
monkey, African green:kidney Top | ||||||
Japan Domestic use only | monkey, African green | kidney | JCRB9126 | BS-C-1 | Kidney cell line of the african green monkey. | |
Japan Domestic use only | monkey, African green | kidney | IFO50413 | BS-C-1 | suitable host for transfection experiments of SV40 vectors | |
Japan Domestic use only | monkey, African green | kidney | JCRB9082 | COS-1 | SV40 transformed African green monkey kidney | |
Japan Domestic use only | monkey, African green | kidney | JCRB9127 | COS-7 | African green monkey cell line producing T antigen of SV40. | |
Japan Domestic use only | monkey, African green | kidney | IFO50068 | COS-7 | This line is a transformant derived from CV-1 cell by origin gene-defective mutant of SV40 virus. This cell line is useful for transfection of expression plasmid. | |
Japan Domestic use only | monkey, African green | kidney | JCRB9049 | CV-1 | kidney, highly susceptible to SV40 infection | |
Japan Domestic use only | monkey, African green | kidney | JCRB0111 | VERO | African Green Monkey kidney normal cell line. | |
Japan Domestic use only | monkey, African green | kidney | JCRB9013 | VERO | normal, contact inhibited | |
Japan Domestic use only | monkey, African green | kidney | IFO50471 | Vero | useful to assay mycoplasmas | |
Japan Domestic use only | monkey, African green | kidney | JCRB9007 | VERO 76 | normal, contact inhibited, lower saturation density than the original Vero | |
Japan Domestic use only | monkey, African green | kidney | IFO50410 | VERO 76 | Subclone of the VERO cells. | |
monkey, Cynomolgus:hemo-lymphocytic Top | ||||||
Japan Domestic use only | monkey, Cynomolgus | hemo-lymphocytic | JCRB1646 | HSC-3 | Peripheral blood lymphocyte cell line of cynomolgus monkey (immortalized by Herpesvirus saimiri). | |
Japan Domestic use only | monkey, Cynomolgus | hemo-lymphocytic | JCRB1652 | HSC-4 | Peripheral blood lymphocyte cell line of cynomolgus monkey (immortalized by Herpesvirus saimiri). | |
Japan Domestic use only | monkey, Cynomolgus | hemo-lymphocytic | JCRB1164 | HSC-F | T-cell line (fetal spleen-derived lymphocytes) of cynomolgus monkey. | |
monkey, Cynomolgus:kidney Top | ||||||
Japan Domestic use only | monkey, Cynomolgus | kidney | JCRB0607.1 | MK.P3 | Serum free cell culture of the MK(monkey kidney, JTC-12) cell. | |
Japan Domestic use only | monkey, Cynomolgus | kidney | JCRB0607 | MK.P3(F) | other name is JTC-12.P3(F) | |
monkey, rhesus:hemo-lymphocytic Top | ||||||
Japan Domestic use only | monkey, rhesus | hemo-lymphocytic | JCRB1644 | HSR-1 | Peripheral blood lymphocyte cell line of rhesus monkey (immortalized by Herpesvirus saimiri). | |
Japan Domestic use only | monkey, rhesus | hemo-lymphocytic | JCRB1641 | HSR-4 | Peripheral blood lymphocyte cell line of rhesus monkey (immortalized by Herpesvirus saimiri). | |
mosquito:hatched larvae Top | ||||||
mosquito | hatched larvae | IFO50010 | C6/36 | This cell line is useful for replication of flavoviruses and dengue virus. | ||
mouse: Top | ||||||
mouse | JCRB1621 | hTf2-9F/sf | This cell line produce monoclonal antibody against human transferrin. | |||
mouse | JCRB1632 | VV-1H831 | Mouse hybridoma producing mAb (IgG1) to hemagglutinine (HA) of vaccinia virus. | |||
mouse:adrenal cortex Top | ||||||
mouse | adrenal cortex | JCRB9056 | Y-1 | adrenocortical tumor, steroid-secreting, (LAF1 mouse) | ||
mouse:antibody-producing hybridoma Top | ||||||
mouse | antibody-producing hybridoma | JCRB0013 | 16-8 | Mouse hybridoma cell line producing monoclonal antibody to human erythrocyte. | ||
mouse | antibody-producing hybridoma | JCRB0014 | 19-7 | Mouse hybridoma cell line producing monoclonal antibody to human erythrocyte. | ||
mouse | antibody-producing hybridoma | JCRB0084 | 4-2D | anti-primase complexed with DNA polymerase alpha | ||
mouse | antibody-producing hybridoma | JCRB0083 | 4-8H | anti-DNA polymerase alpha, IgG1 | ||
mouse | antibody-producing hybridoma | IFO50284 | A2B5 clone 105 | Produces anti-chick retinal neuron glycolipid monoclonal antibody (IgM class). | ||
mouse | antibody-producing hybridoma | JCRB1392 | AS17 | Hybridoma cell line producing antibody against human annexin IV. | ||
mouse | antibody-producing hybridoma | JCRB1213.3 | DIG104.10H.1 | Mouse hybridoma cell line producing monoclonal antibody against digoxin. | ||
mouse | antibody-producing hybridoma | JCRB1213.2 | DIG222.4D.5 | Mouse hybridoma cell line producing monoclonal antibody against digoxin. | ||
mouse | antibody-producing hybridoma | JCRB1324 | F119 | Mouse hybridoma cell line producing F119 MAb against CD307(IRTA2/FcRH5/FCRL5). | ||
mouse | antibody-producing hybridoma | JCRB1323 | F25 | Mouse hybridoma cell line producing F25 MAb against CD307 (IRTA2/FcRH5/FCRL5). | ||
mouse | antibody-producing hybridoma | JCRB1189 | F56 | Mouse hybridoma cell line producing F56 MAb against CD307(IRTA2/FcRH5/FCRL5). | ||
mouse | antibody-producing hybridoma | JCRB1226 | GHBP116 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone receptor (GHBP116). | ||
mouse | antibody-producing hybridoma | JCRB1381 | HBs128 | Mouse hybridoma cell line producing monoclonal antibody against HBs antigen. | ||
mouse | antibody-producing hybridoma | JCRB1380 | HBs320 | Mouse hybridoma cell line producing monoclonal antibody against HBs antigen. | ||
mouse | antibody-producing hybridoma | JCRB1222.01 | HGH1.1.3 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.08 | HGH1.11.1 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.09 | HGH1.15.3 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.03 | HGH1.17.2 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.12 | HGH1.31.3 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.13 | HGH1.32.4 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.04 | HGH1.35.2 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.14 | HGH1.37.3 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.10 | HGH1.41.1 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.11 | HGH1.46.1 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.02 | HGH1.6.5 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.07 | HGH1.8.1 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.06 | HGH1.9.3 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.15 | HGH2.4.2 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1222.05 | HGH2.6.1 | Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). | ||
mouse | antibody-producing hybridoma | JCRB1314 | HPSV178-4-3 | Hybridoma cell line producing mAb HPSV178, against the C-terminal portion of PrPSV (residues 214-230). | ||
mouse | antibody-producing hybridoma | JCRB1603 | hTf18-10C | This cell line produce monoclonal antibody against human transferrin. | ||
mouse | antibody-producing hybridoma | JCRB1611 | hTf18-10C/sf | This cell line produce monoclonal antibody against human transferrin. | ||
mouse | antibody-producing hybridoma | JCRB1504 | hTf2-9F | This cell line produces monoclonal antibody against human transferrin. | ||
mouse | antibody-producing hybridoma | JCRB1613 | hTf26-9B | This cell line produce monoclonal antibody against human transferrin. | ||
mouse | antibody-producing hybridoma | JCRB1599 | hTf30-8H | This cell line produce monoclonal antibody against human transferrin. | ||
mouse | antibody-producing hybridoma | JCRB1602 | hTf30-8H/sf | This cell line produce monoclonal antibody against human transferrin. | ||
mouse | antibody-producing hybridoma | JCRB1617 | hTf9-11E | This cell line produce monoclonal antibody against human transferrin. | ||
mouse | antibody-producing hybridoma | JCRB0090 | MB86 | anti-Igh6-4 antibody-producing, IgM, (BALB/c mouse) | ||
mouse | antibody-producing hybridoma | JCRB1342.06 | MOR115.1.13 | Mouse hybridoma cell line producing monoclonal antibody against morphine. | ||
mouse | antibody-producing hybridoma | JCRB1342.07 | MOR124.2.2 | Mouse hybridoma cell line producing monoclonal antibody against morphine. | ||
mouse | antibody-producing hybridoma | JCRB1342.08 | MOR131.5.13 | Mouse hybridoma cell line producing monoclonal antibody against morphine. | ||
mouse | antibody-producing hybridoma | JCRB1342.09 | MOR158.1.3 | Mouse hybridoma cell line producing monoclonal antibody against morphine. | ||
mouse | antibody-producing hybridoma | JCRB1342.11 | MOR180.2.4 | Mouse hybridoma cell line producing monoclonal antibody against morphine. | ||
mouse | antibody-producing hybridoma | JCRB1342.10 | MOR33.2.9 | Mouse hybridoma cell line producing monoclonal antibody against morphine. | ||
mouse | antibody-producing hybridoma | JCRB1342.02 | MOR35.4.12 | Mouse hybridoma cell line producing monoclonal antibody against morphine. | ||
mouse | antibody-producing hybridoma | JCRB1342.03 | MOR39.3.9 | Mouse hybridoma cell line producing monoclonal antibody against morphine. | ||
mouse | antibody-producing hybridoma | JCRB1342.12 | MOR44.4.1 | Mouse hybridoma cell line producing monoclonal antibody against morphine. | ||
mouse | antibody-producing hybridoma | JCRB1342.04 | MOR76.7F.16 | Mouse hybridoma cell line producing monoclonal antibody against morphine. | ||
mouse | antibody-producing hybridoma | JCRB1342.01 | MOR8.2.1 | Mouse hybridoma cell line producing monoclonal antibody against morphine. | ||
mouse | antibody-producing hybridoma | JCRB1342.05 | MOR83.3.10 | Mouse hybridoma cell line producing monoclonal antibody against morphine. | ||
mouse | antibody-producing hybridoma | JCRB1304 | MT-45-5-3 | Mouse hybridoma cell line producing monoclonal antibody against metallothionein. | ||
mouse | antibody-producing hybridoma | IFO50279 | NKY113 | SP21/0-Ag14 myeloma x spleen from mouse immunized with a human colon adenocarcinoma SW1116. This cell line produces MSW113 monoclonal antibody. MSW113 monoclonal antibody recognizes a cancer associated antigenm sialyl-Le^a oligosaccharide. | ||
mouse | antibody-producing hybridoma | JCRB1316.2 | OHP101.B11.1 | Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. | ||
mouse | antibody-producing hybridoma | JCRB1316.3 | OHP138.H8.1 | Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. | ||
mouse | antibody-producing hybridoma | JCRB1316.4 | OHP1E9.3.1 | Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. | ||
mouse | antibody-producing hybridoma | JCRB1316.1 | OHP57.G6.1 | Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. | ||
mouse | antibody-producing hybridoma | JCRB1316.6 | OHP7D7.2.3 | Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. | ||
mouse | antibody-producing hybridoma | IFO50466 | RC1 | This cell line produces a monoclonal antibody RC1 (IgG class). Immunochistochemically, RC1 antibody reacts with radial glia and neural progenitor cells in CNS. | ||
mouse | antibody-producing hybridoma | JCRB0195 | RP-1 | Mouse cell line producing IgG1 against rat neutrophil. | ||
mouse | antibody-producing hybridoma | JCRB0196 | RP-3 | Mouse cell line producing IgM antibody against rat neutrophil. The antibody is harmfull to the rat neutrophil in vivo or in vitro with complement. | ||
mouse | antibody-producing hybridoma | JCRB0011 | S.CET.M8.1.1 | Mouse hybridoma cell line releasing monoclonal anti-11-deoxycortisol antibody. | ||
mouse | antibody-producing hybridoma | JCRB1301 | SC78.H81.C81.A9 | Mouse hybridoma cell line producing monoclonal antibody against scopolamine. | ||
mouse | antibody-producing hybridoma | JCRB9032 | SJK-237-71 | anti-DNA polymerase alpha, IgG1 | ||
mouse | antibody-producing hybridoma | JCRB1358.04 | SRBC-F12-1-19 | Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). | ||
mouse | antibody-producing hybridoma | JCRB1358.05 | SRBC-F12-18-7 | Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). | ||
mouse | antibody-producing hybridoma | JCRB1358.06 | SRBC-F23-20-22 | Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). | ||
mouse | antibody-producing hybridoma | JCRB1358.08 | SRBC-F31-19-1 | Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). | ||
mouse | antibody-producing hybridoma | JCRB1358.07 | SRBC-F31-2-11 | Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). | ||
mouse | antibody-producing hybridoma | JCRB1358.01 | SRBC-P13-7-3 | Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). | ||
mouse | antibody-producing hybridoma | JCRB1358.02 | SRBC-P18-3-8 | Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). | ||
mouse | antibody-producing hybridoma | JCRB1358.03 | SRBC-P20-13-13 | Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). | ||
mouse | antibody-producing hybridoma | JCRB1358.11 | SRBC-RF29-1-3 | Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). | ||
mouse | antibody-producing hybridoma | JCRB1358.10 | SRBC-RP8-18-15 | Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). | ||
mouse | antibody-producing hybridoma | JCRB1358.09 | SRBC-RP8-2-4 | Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). | ||
mouse | antibody-producing hybridoma | JCRB9033 | STK1 | anti-DNA polymerase alpha, IgG1 | ||
mouse | antibody-producing hybridoma | JCRB1311 | ZEN | Mouse hybridoma cell line producing monoclonal antibody against zearalenone. | ||
mouse:ascites Top | ||||||
mouse | ascites | JCRB9090 | Ehrlich ascites | Ehrlich-Lettre ascites carcinoma | ||
mouse | ascites | JCRB0424 | JTC-11 | In vitro adapted strain of Ehrlich ascites carcinoma. | ||
mouse:bladder Top | ||||||
mouse | bladder | IFO50041 | MBT2 | bladder carcinoma | ||
mouse:bone marrow Top | ||||||
mouse | bone marrow | JCRB1181 | 9-15c | Mouse C3H/He cell line. | ||
mouse | bone marrow | JCRB1548 | H-1A(H123) | Mouse bone marrow-derived osteoblast-like cell line. | ||
mouse | bone marrow | JCRB1570 | H-1D(H162) | Mouse bone marrow-derived osteoblast-like cell line. | ||
mouse | bone marrow | JCRB1176 | KUM10 | Osteoblast cell line from mouse C57/B6 bone marrow. | ||
mouse | bone marrow | JCRB1134 | KUM3 | Osteoblast cell line from Mouse C3H bone marrow. | ||
mouse | bone marrow | JCRB1135 | KUM4 | Osteoblastic cell line of mouse C3H. | ||
mouse | bone marrow | JCRB1178 | KUM5 | Osteoblastic cell line of mouse C3H. | ||
mouse | bone marrow | JCRB1202 | KUM6 | Osteoblastic cell line | ||
mouse | bone marrow | JCRB1204 | KUM7 | Osteoblastic cell line | ||
mouse | bone marrow | JCRB1139 | KUM9 | Osteoblastic cell line of mouse C3H. | ||
mouse | bone marrow | JCRB1132 | KUSA-0 | Mouse osteoblastic cell line. | ||
mouse | bone marrow | JCRB1119 | KUSA-A1 | Mouse osteoblastic cell line. | ||
mouse | bone marrow | JCRB1129 | KUSA-H1 | mouse osteoblastic cell line | ||
mouse | bone marrow | JCRB1138 | NRG | Osteoblastic cell line of mouse C3H. | ||
mouse:embryo Top | ||||||
mouse | embryo | JCRB1355 | 1-1ras1000 | The ras-transformed BALB/c 3T3 A31-1-1variant cell lines were strongly tumorinenic, but the cells were not metastatic. (Strain problem was found. Refer Important Notice at cell detail page.) | ||
mouse | embryo | JCRB1357 | 1-1src | The src-transformed BALB/c 3T3 A31-1-1 variant cell lines were strongly tumorinenic and metastatic.(Strain problem was found. Refer Important Notice at cell detail page.) | ||
mouse | embryo | JCRB9014 | 3T3 L1 | Clonal subline of the mouse 3T3 that accumulate large amounts of triglyceride fat when the cells are in the resting state. | ||
mouse | embryo | IFO50416 | 3T3-L1 | 3T3 L1 cell line is a substrain of 3T3-Swiss albino cell line. 3T3 L1 cells convert adipose-like cells at confluent. | ||
mouse | embryo | JCRB9019 | 3T3-Swiss albino | fibroblast, contact inhibited, (Swiss albino mouse) | ||
mouse | embryo | IFO50417 | 3T3-Swiss albino | fibroblast, contact inhibited, (Swiss albino mouse) | ||
mouse | embryo | JCRB9059 | 3T6-Swiss albino | fibroblast, collagen-secreting, (Swiss albino mouse) | ||
mouse | embryo | JCRB1356 | A31-1-1 | fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.) | ||
mouse | embryo | IFO50021 | A31-714 C4 | fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse) | ||
mouse | embryo | JCRB0601 | BALB/3T3 A31-1-1 | fibroblast, contact inhibited, (Strain problem was found. Refer Important Notice at cell detail page.) | ||
mouse | embryo | JCRB9005 | BALB/3T3 clone A31 | fibroblast, contact inhibited, (BALB/c mouse) | ||
mouse | embryo | IFO50070 | Balb/3T3-A31-1-1 | fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.) | ||
mouse | embryo | IFO50299 | Balb/c 3T3 A31-1-13 | fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.) | ||
mouse | embryo | IFO50298 | Balb/c 3T3 A31-I-1 | fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.) | ||
mouse | embryo | JCRB0149 | Bhas 42 | BALB 3T3 A31-1-1 cell line transfected with H-ras gene. The cell line keeps characteristics of the contact inhibition and the transfomation is induced by phorbol ester alone. No initialization required. (Strain problem was found. Refer Important Notice at cell detail page.) | ||
mouse | embryo | JCRB9080 | C3H/10T1/2 clone 8 | fibroblast, contact inhibited, (C3H mouse) | ||
mouse | embryo | JCRB0003 | C3H/10T1/2-clone 8 | fibroblast, contact inhibited, (C3H mouse) | ||
mouse | embryo | IFO50415 | C3H/10T1/2-clone8 | This cell line is useful for transformation studies. | ||
mouse | embryo | IFO50042 | C3H/MCA clone 15 | Parent strain is C3H/10T/1/2 clone 8. | ||
mouse | embryo | JCRB0712 | MCA-TCL16 | C3H10T1/2 cl-8 derivative, methylcholanthrene-transformed, (C3H mouse) This cell line is found to be contaminated by mycoplasmas. | ||
mouse | embryo | JCRB1914 | MEF-N7 | Mouse Embryonic Fibroblast, derived from 12.5 day old, ICR | ||
mouse | embryo | IFO50019 | NIH 3T3 p-7 cl-3 | fibroblast (NIH Swiss mouse) | ||
mouse | embryo | JCRB0615 | NIH/3T3 clone 5611 | A cell line which was established from NIH Swiss mouse embryo. | ||
mouse | embryo | JCRB9099 | SV-T2 | SV40 virus-transformed BALB/3T3, (BALB/c mouse) | ||
mouse:fibroblast Top | ||||||
mouse | fibroblast | JCRB0732 | A9(0439)-1 | contains human chromosome Xpter>Xq26::3p12>3pter (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB0730 | A9(2621)-4 | contains human chromosome 12pter>12q24::Xq22>Xqter (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB0731 | A9(3552)-2 | contains human chromosome 11pter>11q23::Xq26>Xqter (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB0729 | A9(3884)-1 | contains human chromosome 16pter>16q24::Xq26>Xqter (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB0728 | A9(7151)-3 | contains human chromosome 17pter>17q11::Xq11>Xqter (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB0727 | A9(An4)-2 | contains human chromosome # 1 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2210 | A9(Bsr10) | contains human chromosome #10 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2223 | A9(BsrX) | contains human chromosome X (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2213 | A9(Hygro13) | contains human chromosome #13 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2214 | A9(Hygro14) | contains human chromosome #14 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2221 | A9(Hygro21) | contains human chromosome #21 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2222 | A9(Hygro22) | contains human chromosome #22 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2201 | A9(Neo1) | contains human chromosome # 1 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2211 | A9(neo11) | contains human chromosome #11 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2212 | A9(Neo12) | contains human chromosome #12 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2215 | A9(Neo15) | contains human chromosome #15 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2216 | A9(Neo16) | contains human chromosome #16 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2217 | A9(Neo17) | contains human chromosome #17 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2218 | A9(Neo18) | contains human chromosome #18 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2219 | A9(Neo19) | contains human chromosome #19 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2202 | A9(Neo2) | contains human chromosome # 2 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2220 | A9(Neo20) | contains human chromosome #20 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2203 | A9(Neo3) | contains human chromosome # 3 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2204 | A9(Neo4) | contains human chromosome # 4 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2205 | A9(Neo5) | contains human chromosome # 5 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2206 | A9(Neo6) | contains human chromosome # 6 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2207 | A9(Neo7) | contains human chromosome # 7 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB2208 | A9(Neo8) | contains human chromosome # 8 (MTA with Tottori Univ. is required.) | ||
mouse | fibroblast | JCRB0726 | A9(NTI8)-2 | contains human chromosome # 7 (MTA with Tottori Univ. is required.) | ||
mouse:hemo-lymphocytic Top | ||||||
mouse | hemo-lymphocytic | JCRB0238 | B8/3 | Mouse erythroleukemia cell line. | ||
mouse | hemo-lymphocytic | JCRB9117 | BCL1 Clone CW13.20 | Mouse B cell line, where the differentiation is stimulated by B cell differentiation factors. | ||
mouse | hemo-lymphocytic | JCRB9002 | BW5147.G.1.4.OUA-R.1 | lymphoma, T cell lymphoma, (AKR/J mouse) | ||
mouse | hemo-lymphocytic | JCRB1350 | EL-4 | EL-4 was established from a lymphoma induced in a C57BL mouse by 9,10-dimethyl-1,2-benzanthracene. | ||
mouse | hemo-lymphocytic | JCRB1352 | EL-4ad | A valiant cell line which adhered to a tissue culture dish was isolated from highly metastatic EL-4 murine T-lymphoma. | ||
mouse | hemo-lymphocytic | IFO50111 | GRSL | thymic leukemia, (GR/A mouse) | ||
mouse | hemo-lymphocytic | JCRB0018 | J774.1 | monocyte-macrophage, IL-1-producing, (BALB/c mouse) | ||
mouse | hemo-lymphocytic | JCRB9026 | L1210 | leukemia, lymphocytic, (DBA/2 mouse) | ||
mouse | hemo-lymphocytic | JCRB0709 | L5178Y | lymphoma, methylcholanthrene induced, (DBA/2 mouse) | ||
mouse | hemo-lymphocytic | JCRB0709.1 | L5178Y TK+/-3.7.2c | Mouse TK+/- heterozygotic subline of the L5178Y. | ||
mouse | hemo-lymphocytic | JCRB0723 | L5178Y ts2 | L5178Y derivative, abnormal cell division at non-permissive temperature | ||
mouse | hemo-lymphocytic | JCRB0724 | L5178Y ts39 | A ts strain derived from L5178Y. Micronucleation observed at the non-permissive temperature (39 C). | ||
mouse | hemo-lymphocytic | IFO50006 | M1 | Spontaneously occurred mouse myeloid leukemia, differentiate into macrophage/granulocyte. | ||
mouse | hemo-lymphocytic | JCRB0110 | M1-T22 | Spontaneously occured myeloid leukemia cell line differentiated by dexamethasone or etc. | ||
mouse | hemo-lymphocytic | IFO50008 | Mm1 | spontaneous myeloid leukemia, M-1-derivative, macrophage-like phenotype, (SL mouse) | ||
mouse | hemo-lymphocytic | JCRB9106 | MPC 11 OUAr | myeloma, ourbain resistant | ||
mouse | hemo-lymphocytic | JCRB0078 | P-815 | mastocytoma, (DBA/2 mouse) | ||
mouse | hemo-lymphocytic | JCRB9109 | P3.6.2.8.1 | myeloma, IgG1 secreting, (BALB/c mouse) | ||
mouse | hemo-lymphocytic | JCRB0009 | P3/NS1/1-Ag4-1 | Mouse plasmacytoma cell line resistant to 8-azaguanine. | ||
mouse | hemo-lymphocytic | JCRB9107 | P3/NS1/1-Ag4-1(NS-1) | myeloma, plasmacytoma, non-secreting, 8-azaguanine resistant | ||
mouse | hemo-lymphocytic | JCRB0017 | P388 | MCA induced lymphoid mouse neoplasma cell line. | ||
mouse | hemo-lymphocytic | JCRB0016 | P388-D1 | lymphoid neoplasm, derived from P388, (DBA/2 mouse) | ||
mouse | hemo-lymphocytic | IFO50036 | P388D1 | lymphoid neoplasm, derived from P388, (DBA/2 mouse) | ||
mouse | hemo-lymphocytic | JCRB0708 | P3U1 | myeloma | ||
mouse | hemo-lymphocytic | JCRB9030 | P3X63-Ag8.653 | myeloma, non-secreting, 8-azaguanine resistant, (BALB/c mouse) | ||
mouse | hemo-lymphocytic | JCRB9105 | P3X63Ag8 | myeloma, plasmacytoma, IgG1(gamma,kappa) secreting, (BALB/c mouse) | ||
mouse | hemo-lymphocytic | JCRB9085 | P3X63Ag8U.1 | myeloma, plasmacytoma, 8-azaguanine resistant, (BALB/c mouse) | ||
mouse | hemo-lymphocytic | JCRB0113 | PAI | myeloma, (BALB/c mouse) | ||
mouse | hemo-lymphocytic | IFO50267 | PB-3c | IL-3-dependent mouse bone marrow cell line. | ||
mouse | hemo-lymphocytic | JCRB9084 | Sp2/O-Ag14 | myeloma, non-secreting, 8-azaguanine resistant | ||
mouse | hemo-lymphocytic | JCRB9093 | WEHI-3 | leukemia, myelomonocytic, macrophage-like, (BALB/c mouse) | ||
mouse | hemo-lymphocytic | IFO50296 | WEHI-3b | myelomonocyte, (BALB/c mouse) | ||
mouse:hybridoma Top | ||||||
mouse | hybridoma | JCRB1213.1 | DIG64.2B.5 | Mouse hybridoma cell line producing monoclonal antibody against digoxin. | ||
mouse | hybridoma | JCRB1316.5 | OHP4B2.2.3 | Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. | ||
mouse:kidney Top | ||||||
mouse | kidney | IFO50373 | TKC2 | cAMP synthesis is stimulated by arginine vasopressin in the cells. Growth temperature is 33 C. | ||
mouse:liver Top | ||||||
mouse | liver | IFO50377 | FLS3 | This cell line supports B-cell differentiation. (Blood, 77,2612,(1991)). | ||
mouse | liver | IFO50378 | FLS5 | Mouse liver stromal cell line. | ||
mouse | liver | JCRB9075 | NCTC Clone 1469 | Normal cell line from mouse liver. | ||
mouse | liver | IFO50080 | NCTC clone 1469 | The NCTC clone 1469 is a subline of NCTC 721. | ||
mouse | liver | IFO50379 | TLR2 | P450IA1 mRNA is induced by methylcholanthrene. Growth temperature is 33 C. | ||
mouse | liver | IFO50380 | TLR3 | P450IA1 mRNA is induced by methylcholanthrene. Growth temperature is 33 C. | ||
mouse:lung Top | ||||||
mouse | lung | JCRB1349 | Ex-3LL | Variant cell line possessing enhanced lung metastasis ability derived from Lewis lung cancer (3LL). | ||
mouse | lung | JCRB1351 | Int-3LL | Variant cell line possessing enhanced intravasating ability derived from Lewis lung cancer (3LL). | ||
mouse:lung cancer Top | ||||||
mouse | lung cancer | JCRB1348 | 3LL | Lewis lung carcinoma cell line. | ||
mouse:macrophage Top | ||||||
mouse | macrophage | JCRB9108 | J774A.1 | Mouse macrophage cell line. | ||
mouse:mammary Top | ||||||
mouse | mammary | JCRB0233.0 | BALB-MC | mammary cancer, (BALB/cHe mouse) | ||
mouse | mammary | JCRB0233.1 | BALB-MC.D3 | mammary cancer, (BALB/cHe mouse) | ||
mouse | mammary | JCRB0233.2 | BALB-MC.E12 | Mouse mammary tumor cell line. | ||
mouse | mammary | JCRB1077 | DD-762 | Mouse mammary tumor cell line producing MuMTV. | ||
mouse | mammary | JCRB0701 | FM3A | mammary carcinoma, spontaneously obtained, (C3H/He mouse) | ||
mouse | mammary | JCRB0703 | FM3A APRT~ | mammary carcinoma, APRT-deficient FM3A, (C3H/He mouse) | ||
mouse | mammary | JCRB0702 | FM3A HPRT~ | mammary carcinoma, HPRT-deficient FM3A , (C3H/He mouse) | ||
mouse | mammary | JCRB0704 | FM3A TK~ | mammary carcinoma, thymidine kinase-deficient FM3A, (C3H/He mouse) | ||
mouse | mammary | JCRB9077 | MMT 060562 | spontaneous mammary tumor | ||
mouse | mammary | JCRB1413 | ST 13 | Mouse normal preadipocyte cell line established from ddN mouse. ST 13 can be induced to differentiate into fat-accumulating cells in vitro. | ||
mouse | mammary | JCRB0705 | ts85 | FM3A derivative, defective in ubiquitin activating enzyme, (C3H mouse) | ||
mouse | mammary | JCRB0706 | tsFT101 | FM3A derivative, cytokinesis is blocked at 39 C, (C3H mouse) | ||
mouse:melanoma Top | ||||||
mouse | melanoma | JCRB0202 | B16 melanoma | Mouse skin melanoma cell line. | ||
mouse:neural Top | ||||||
mouse | neural | IFO50519 | A1 | derives from p53-deficient mouse brain, used for preparation of conditioned medium for MG5 cells | ||
mouse | neural | IFO50424 | AP-16 | Astrocyte differentiation is induced by TGF-beta, LIF, CNTF and serum The deprivation of EGF induces death of AP-16 cells by apoptosis. | ||
mouse | neural | JCRB1571 | F6B3 | Mouse cell line derived from mouse brain tumor. | ||
mouse | neural | IFO50161 | KT-5 | GFAP and S-100-positive, MBP, thy-1 and neurofilament-negative. (Tested at the IFO.). | ||
mouse | neural | IFO50293 | MA-89 | Not immortalized cells. Limited life span. | ||
mouse | neural | JCRB0145 | MEB 5 | Multipotent CNS stem cell line of mouse. Cells differentiate into neuron, astrocytes and oligodendrocytes. | ||
mouse | neural | IFO50472 | MEB5 | Neural stem cell line established from embryonic 14.5 day mouse cerebrum by E7 oncogene of HPV type 16. Withdrawal of EGF induces apoptosis or differentiation to neurons, astrocytes, and oligodendrocytes. LIF induces differentiation into astrocytes. | ||
mouse | neural | IFO50520 | MG5 | A microglial cell line from p53-deficient mice. Requires conditioned medium of A1 cell line (or of astrocytes) for cultivation of MG5 cells. | ||
mouse | neural | IFO50081 | Neuro-2a | Derivative of C1300 tumor. C1300 tumor was originally described as a spontaneous tumor of the region of spinal cord. Later studies suggested that it is drived from sympathetic cells in peripheral nervous system. | ||
mouse | neural | IFO50495 | Neuro-2aTG | This cell line is HPRT-deficient clone from EMS-mutagnenized Neuro-2a cells. HAT-sensitive, 6-thioguanine-registant. | ||
mouse | neural | JCRB1574 | RSV-M | Mouse cell line derived from mouse brain tumor. | ||
mouse | neural | JCRB1580 | SR-CDF1 DBT | Mouse cell line derived from mouse brain tumor. | ||
mouse | neural | JCRB1361 | Vn1919 | neuroglial and neuronal character coexpressing ependymoma cell line. | ||
mouse | neural | JCRB1365 | Vn1919 cl4 | neuroglial and neuronal character coexpressing ependymoma cell line. | ||
mouse | neural | JCRB1367 | Vn1919 cl49 | neuroglial and neuronal character coexpressing ependymoma cell line. | ||
mouse | neural | JCRB1368 | Vn1919 cl59 | neuroglial and neuronal character coexpressing ependymoma cell line. | ||
mouse:olfactory epithelium Top | ||||||
mouse | olfactory epithelium | IFO50484 | DBC1.2 | This cell line is likely to be derived from olfactory dark (horizontal) basal cell. Keratin is expressed in this cell line. | ||
mouse:ovary Top | ||||||
mouse | ovary | JCRB1026 | OV3121 | A non-metastatic epitherial tumor cell line established from ovarian granulosa cell tumor irradiated with 60-Co-gamma rays. Cells are producing estradiol continuously. | ||
mouse | ovary | JCRB0186 | OV3121ras4 | Mouse ovarian granulosa cell tumor line with v-Ha-ras gene. | ||
mouse | ovary | JCRB0187 | OV3121ras7 | Mouse ovarian granulosa cell tumor line with v-Ha-ras gene. | ||
mouse | ovary | JCRB0151.1 | p53-def-MOSE | ovarian surface epithelial cell line from p53(-/-) mouse | ||
mouse | ovary | JCRB0151 | T-Ag-MOSE | Cells are derived from normal ovary of adult C3H/He mouse and immortalized by the plasmid pEF321-T containing T antigen gene. Cells are tumorigenic in nude mice. | ||
mouse:pituitary Top | ||||||
mouse | pituitary | JCRB9098 | AtT-20 | pituitary tumor, ACTH producing, (LAF1 mouse) | ||
mouse:sarcoma Top | ||||||
mouse | sarcoma | JCRB9089 | CCRF S-180 II | S-180 sarcoma derivative | ||
mouse | sarcoma | IFO50268 | EHS | This cell line secretes basement membrane matrix including laminin and type IV collagen. | ||
mouse:skin Top | ||||||
mouse | skin | JCRB0211 | A9 | skin fibroblast, 8-azaguanine-resistant, (C3H mouse) | ||
mouse | skin | JCRB0212 | B82 | skin fibroblast, bromodeoxyuridine-resistant | ||
mouse | skin | JCRB1198.01 | GP8 | The mouse SV cell line rescued with a human normal behta-galactosidase gene. | ||
mouse | skin | JCRB1225 | I51T | Mouse behta-galactosidase deficient cell line introduced human defcient bethta-galactosidase gene. | ||
mouse | skin | JCRB0125 | L alpha | L cell line introduced with poliovirus receptor protein alpha gene, thymidine kinase defective | ||
mouse | skin | JCRB0722 | L cl 1D | fibroblast, thymidine kinase-deficient, (C3H mouse) | ||
mouse | skin | JCRB0648 | L.P3 | Serum free cell line of the mouse L929 cell line. | ||
mouse | skin | JCRB0605 | L.P3(S) | L cell derived, can grow in a serum-free medium, (C3H mouse) | ||
mouse | skin | JCRB1322 | m5S | Near-diproid mouse embryonic cell line. | ||
mouse | skin | JCRB9003 | NCTC Clone 929 | fibroblast, subclone of strain L, (C3H/An mouse) | ||
mouse | skin | IFO50409 | NCTC clone 929 | A clone of L cells, and often referred as L929. The L cells was established from normal subcutaneous areolar and adipose tissue. | ||
mouse | skin | JCRB1207 | SV | SV40 immortalized beta-galactosidase gene deficient mouse fibroblast cell line. Human disease animal model mouse (GM1 gangliosidosis) derived cell line. | ||
mouse:spleen Top | ||||||
mouse | spleen | IFO50375 | MSS31 | spleen stromal cell line, (C57BL/6 mouse) | ||
mouse | spleen | IFO50376 | MSS62 | spleen stromal cell line, (C57BL/6 mouse) | ||
mouse:teratoma Top | ||||||
mouse | teratoma | JCRB0721 | F9 | teratocarcinoma, differentiation-inducible, (129/Sv mouse) | ||
mouse | teratoma | JCRB0001 | F9-41 | Mouse testicular teratocarcinoma cell line. | ||
mouse | teratoma | JCRB0720 | OTT6050 | teratocarcinoma, (129/Sv mouse) | ||
mouse | teratoma | JCRB0206 | PCC4 AG | teratocarcinoma, 8-azaguanine-resistant, (129/Sv mouse) | ||
mouse | teratoma | JCRB0216 | PCC4 AG Cap | teratocarcinoma, 8-azaguanine, chloramphenicol-resistant (129/sv mouse) | ||
mouse:testis Top | ||||||
mouse | testis | JCRB0243 | B-1 | Leydig cell tumor, estrogen-dependent, (BALB/c mouse) | ||
mouse | testis | JCRB9097 | I-10 | Leydig cell testicular tumor (BALB/cJ mouse) | ||
mouse:thymidylate defective Top | ||||||
mouse | thymidylate defective | JCRB0719 | FSthy21 | complete defective strain of thymidylate synthase, (C3H mouse) | ||
mouse:thymus Top | ||||||
mouse | thymus | IFO50248 | IT-79MTNC3 | thymic nurse cell, (BALB/c mouse) | ||
mouse:vascular system Top | ||||||
mouse | vascular system | JCRB0150 | P53LMACO1 | Smooth muscle cell line established from thoracic aorta of a p53 knock out mouse. | ||
mouse | vascular system | IFO50374 | TKD2 | Acetylated low-densitiy lipoprotein is incorporated into the cells. Temperature sensitive cell line. Growth temperature is 33 C. | ||
mouse x human:antibody-producing hybridoma Top | ||||||
mouse x human | antibody-producing hybridoma | IFO50090 | 4G12 hybridoma | This cell line produces human monoclonal 4G12 antibody (Ig lambda). The 4G12 antibody recognizes a glycoprotein with Mr = 65,000. Immunohistochemically, 4G12 reacts especially with lung carcinomas and with some malignant tumors. | ||
mouse x rat:antibody-producing hybridoma Top | ||||||
mouse x rat | antibody-producing hybridoma | JCRB9092 | 7D4 | anti-murine IL-2 receptors (rat antibody) | ||
mouse x rat | antibody-producing hybridoma | JCRB1385 | CAS-9 | Hybridoma cell line producing antibody against mouse CD49d (VLA-4 a chain). Binding inhibition VLA-4/Fibronectin. | ||
mouse x rat | antibody-producing hybridoma | JCRB1370 | TAS-5 | Hybridoma cell line producing antibody against mouse CD49d (VLA-4 a chain). Binding inhibition VLA-4/VCAM-1 and VLA-4/Fibronectin | ||
mouse x rat | antibody-producing hybridoma | JCRB1353 | TER-119 | Hybridoma cell line producing antibody against mouse erythrocyte membrane antigen Ly76. | ||
mouse x rat:cybrid Top | ||||||
mouse x rat | cybrid | JCRB0203 | PCC4 TypeIII | PCC4 fused with cytoplasts of rat myoblastic cell (L6TG Cap-r) | ||
mouse x rat:neural Top | ||||||
mouse x rat | neural | IFO50221 | N18-RE-105 | Neuron like cells established from mouse N18TG2 x Fischer rat 18 day-embryonic neural retina. | ||
pig:kidney Top | ||||||
Japan Domestic use only | pig | kidney | JCRB0060 | LLC-PK1 | susceptible to rubella, vaccinia and herpes viruses | |
Japan Domestic use only | pig | kidney | JCRB9040 | PK(15) | kidney | |
Japan Domestic use only | pig | kidney | IFO50422 | PKF | The name PKF derives from Pig Kidney Fibroblastic. | |
Japan Domestic use only | pig | kidney | IFO50423 | PKR | The name PKR derives from Pig Kidney Rough (outline of cell morphology). | |
Japan Domestic use only | pig | kidney | IFO50421 | PKS | The name PKS derives from Pig Kidney Smooth (outline of cell morphology). | |
pygmy mouse:tail Top | ||||||
pygmy mouse | tail | JCRB9124 | M.dunni(Clone III8C) | normal, support the growth of all 4 classes of MuLV | ||
rabbit:cornea Top | ||||||
rabbit | cornea | JCRB0246 | RC-1 | cornea, (white rabbit) | ||
rabbit | cornea | JCRB9122 | SIRC | susceptible to rubella virus | ||
rabbit | cornea | IFO50020 | SIRC | susceptible to rubella virus | ||
rabbit:kidney Top | ||||||
rabbit | kidney | JCRB9034 | LLC-RK1 | an aneuploid cell line, (New Zealand white rabbit) | ||
rabbit:lung Top | ||||||
rabbit | lung | JCRB0131 | RL-33 | Japansese white rabbit lung cell line sensitive to HSV or VSV. | ||
rat:colon Top | ||||||
rat | colon | JCRB0167 | RCN-9 | DMH induced colonic cancer, (F344/DuCrj rat) | ||
rat:embryo Top | ||||||
rat | embryo | JCRB0734 | 3Y1-B Clone 1-6 | fibroblast, whole embryo, (Fischer 344 rat) | ||
rat | embryo | IFO50277 | 5RP7 | fibroblast transformed by c-Ha-ras oncogene | ||
rat | embryo | JCRB0737 | Ad12-3Y1-Z19 | 3Y1 derivative, Ad12-transformed, (Fischer rat) | ||
rat | embryo | JCRB0738 | E1A-3Y1-1 | 3Y1 derivative, transformed by E1A of Ad12 virus, (Fischer rat) | ||
rat | embryo | IFO50015 | F2408 | Rat fibroblast cell line. | ||
rat | embryo | JCRB0143.5 | F2408 EBNA2 cl-14 | EBNA2-transfected, (Fischer rat) | ||
rat | embryo | JCRB0143.2 | F2408 EBNA2 cl-16 | F2408 cell line transfected with recombinant plasmid pZE2 with coding region of the EBNA2 and the expression of the EBNA2 was strong in this strain. | ||
rat | embryo | JCRB0143.3 | F2408 EBNA2 cl-18 | Rat embryo cell line transfected by recombinant plasmid pZE2 with coding region of the EBNA2. | ||
rat | embryo | JCRB0143.6 | F2408 EBNA2 cl-23 | This cell line is one of a series of F2408 rat cell lines with recombinant plasmid pZE2 with coding region of the EBNA2 transfected, but the expression of the EBNA2 was weak in this strain. | ||
rat | embryo | JCRB0143.4 | F2408 EBNA2 cl-24 | EBNA2-transfected, (Fischer rat) | ||
rat | embryo | JCRB0143.7 | F2408 EBNA2 cl-28 | F2408 cell line transfected with recombinant plasmid pZE2 having coding region of the EBNA2 but the expression of the EBNA2 was weak. | ||
rat | embryo | JCRB0143.1 | F2408 EBNA2 cl-9 | EBNA2-transfected, (Fischer rat) | ||
rat | embryo | JCRB0143.0 | F2408 pZipNeo | F2408 cell line transfected with pZipNeo plasmid alone as a control against pZE2 transfected F2408 cell line series. | ||
rat | embryo | IFO50099 | F2408-B812 | HGPRT-deficient line from F2408 (IFO 50015). This cell line exhibits temperature sensitive phenotype for transformation by Moloney MSV. | ||
rat | embryo | IFO50100 | F2408-B993 | HGPRT-deficient line from F2408 (IFO 50015). This cell line exhibits temperature sensitive phenotype for transformation by Moloney MSV. | ||
rat | embryo | IFO50101 | F2408-No.20 | Thymidine kinase-deficient line from F2408 (IFO 50015). | ||
rat | embryo | IFO50098 | F2408-No.3 | HGPRT-deficient line from F2408 (IFO 50015). | ||
rat | embryo | IFO50102 | F2408-No.7 | HGPRT-deficient line from F2408 (IFO 50015). | ||
rat | embryo | JCRB0743 | HR-3Y1-2 | 3Y1 derivative, transformed by v-H-ras cDNA, (Fischer rat) | ||
rat | embryo | JCRB0739 | NG-3Y1-T15L | 3Y1 derivative, transformed by MNNG, (Fischer rat) | ||
rat | embryo | JCRB0740 | NG-3Y1-T308 | 3Y1 derivative, transformed by MNNG, (Fischer rat) | ||
rat | embryo | JCRB0741 | NG-3Y1-T6R | 3Y1 derivative, transformed by MNNG, (Fischer rat) | ||
rat | embryo | JCRB0736 | Py-3Y1-S2 | 3Y1 derivative, mouse polyoma virus-transformed, (Fischer rat) | ||
rat | embryo | IFO50282 | RAT-2 | thymidine kinase deficient RAT-1 (F2408) cell line, (Fischer rat) | ||
rat | embryo | JCRB0742 | SR-3Y1-2 | 3Y1 derivative, transformed by Rous sarcoma virus, (Fischer rat) | ||
rat | embryo | JCRB0735 | SV-3Y1-C66 | 3Y1 derivative, SV40-transformed, (Fischer rat) | ||
rat | embryo | JCRB0153.2 | tsJT16 | Rat 3Y1 derived ts mutant cell line for cell cycle progression from G0 and G1 to S phase. | ||
rat | embryo | JCRB0153.3 | tsJT60 | Rat 3Y1 derived ts mutant cell line with cell cycle arrest at G0 phase. | ||
rat | embryo | JCRB0153.1 | tsJT663 | Rat embryo cell line with ts mutation for cell cycle progression from G1 to S phase. | ||
rat:hemo-lymphocytic Top | ||||||
rat | hemo-lymphocytic | JCRB0168 | c-WRT-7-LR | A transplantable rat myelomonocytic leukemia cell line induced in a WKA rat by neonatal injections of RLV (Rauscher leukemia virus). | ||
rat | hemo-lymphocytic | IFO50034 | RBL-1 | leukemia, basophilic (Wistar rat) | ||
rat | hemo-lymphocytic | JCRB0241 | Shay | granurocytic sarcoma, (Wister rat) | ||
rat | hemo-lymphocytic | JCRB9091 | Y3-Ag 1.2.3 | myeloma, kappa secreting, 8-azaguanine resistant, (Lou rat) | ||
rat:kidney Top | ||||||
rat | kidney | IFO50280 | 77N1 | Parental strain is NRK (normal rat kidney) cells (J. Bacteriol.,92, 1133 (1966)). | ||
rat | kidney | JCRB1585 | ACI-RCC | Rat chemically induced renal cell carcinoma cell line. (induced by ferric nitrilotriacetate (Fe-NTA)) | ||
rat | kidney | JCRB9067 | NRK-49F | fibroblastic clone of NRK (normal rat kidney) cells, useful for transformation assays, (Osbone-Mendel rat) | ||
rat | kidney | IFO50481 | NRK-49F | NRK-49F is a fibroblastic clone of NRK (mixed culture of normal rat kidney) cells. (J. Bacteriol., 92, 1133 (1966)). This cell line exhibits contact inhibition and is useful for transformation assays. | ||
rat | kidney | IFO50480 | NRK-52E | NRK-52E is a epithelioid clone of NRK (mixed culture of normal rat kidney) cells. (J. Bacteriol., 92, 1133 (1966)). | ||
rat:leukemia Top | ||||||
rat | leukemia | JCRB0023 | RBL-2H3 | Famous rat mast cell line releasing IgE mediated histamine, established from peripheral blood with basophilic leukemia. | ||
rat:liver Top | ||||||
rat | liver | JCRB0431 | 3'-mRLh-2 | hepatoma, (Donryu rat) | ||
rat | liver | JCRB0421 | 3'-mRLN-30 | liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) | ||
rat | liver | JCRB0422 | 3'-mRLN-31 | liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) | ||
rat | liver | JCRB0408 | Ac2F | normal liver, diploid, (Donryu rat) | ||
rat | liver | JCRB0416 | Ac2F(DT) | Ac2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat) | ||
rat | liver | JCRB0417 | Ac2F(ST) | Ac2F-derived, spontaneously transformed, (Donryu rat) | ||
rat | liver | JCRB0714.1 | AH-7974.P3 | Serum free rat ascited hepatoma cell line. Cells have been maintained by passage for long time. Extremely high passage number. | ||
rat | liver | JCRB0132.1 | AH601(JTC27) | A transplantable rat hepatoma cell line derived from ascites. | ||
rat | liver | JCRB0132.2 | AH601.P3(JTC27) | AH-601 cell line adapted to a serum free medium. | ||
rat | liver | JCRB0132.3 | AH601.P3(JTC27) | AH-601 cell line adupted to a serum free medium with long passage history. | ||
rat | liver | JCRB0411 | AH66tc | ascites hepatoma, (Donryu rat) | ||
rat | liver | JCRB0412 | AH70Btc | ascites hepatoma, (Donryu rat) | ||
rat | liver | JCRB0248 | ARLJ301-3 | liver epithelial cell, (F344/DuCrj rat) | ||
rat | liver | JCRB0025 | BRL-3A | MSA (somatomedin-like) protein producing, (Buffalo rat) | ||
rat | liver | JCRB9114 | BRL-3A | MSA (somatomedin-like) protein producing, (Buffalo rat) | ||
rat | liver | JCRB0409 | dRLa-74 Clone 2 | liver adenoma, (Donryu rat) | ||
rat | liver | JCRB0410 | dRLh-84 | hepatoma, (Donryu rat) | ||
rat | liver | JCRB0418 | dRLN-4 | liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) | ||
rat | liver | JCRB0420 | dRLN-6 | liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) | ||
rat | liver | JCRB0419 | dRLN-9 | liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) | ||
rat | liver | JCRB0249 | FAA-HTC1 | hepatocellular carcinoma, 2-acetylaminofluorene induced, (F344/DuCrj rat) | ||
rat | liver | JCRB1040 | FF101 | Rat hepatoma cell line with producing unidentified growth factor maintained in serum-free RPMI1640 medium for 444 passages. | ||
rat | liver | JCRB0610 | IAR-20 | non-transformed live cell line, (BD-IV rat) | ||
rat | liver | JCRB0714 | JTC-16 P3 | Serum free rat ascites hepatoma cell line. | ||
rat | liver | JCRB0152.1 | M | Cell line which is derived from RLC-3 (JAR rat) after 54 day-culture by Nagisa method with treatment of DAB(10ug/ml) for one week. Cells are capable to form collagen network. | ||
rat | liver | JCRB0152.2 | M.P3 | M cells derived from RLC-3 (JAR rat) was habituated to serum free culture medium. | ||
rat | liver | JCRB0152.3 | M.P3 | M cells derived from RLC-3 (JAR rat) was habituated to serum free culture medium. | ||
rat | liver | JCRB1088 | RI-T | Rat hepatic stellate cell(HSC) line immortalized with SV40 T antigen. | ||
rat | liver | JCRB0247 | RL-34 | normal, collagen-induced growth arrest, (Wistar rat) | ||
rat | liver | JCRB0718 | RLC-10.P3 | Serum free cell culture derived from rat liver. | ||
rat | liver | JCRB0718.1 | RLC-10.P3 | Rat normal cell line cultured with serum free medium for long passages. | ||
rat | liver | JCRB0415 | RLN-10 | normal liver, (Donryu rat) | ||
rat | liver | JCRB0414 | RLN-8 | normal liver, (Donryu rat) | ||
rat | liver | JCRB0402 | RLN-B2 | normal liver, (Donryu rat) | ||
rat | liver | JCRB0407 | RLN-J-5-2 | normal liver, (Donryu rat) | ||
rat | liver | JCRB0193 | WB-F344 | Normal liver epitherial cell line from rat, Fischer-344. | ||
rat:lung Top | ||||||
rat | lung | JCRB0229 | EGV-4T | immortal cell line from MNNG-transformed tracheal epithelial cells | ||
rat | lung | JCRB0608 | JTC19 | lung, (JAR-1 rat) | ||
rat | lung | JCRB9053 | L-2 | adult lung | ||
rat:lymph node Top | ||||||
rat | lymph node | JCRB0144.1 | LYM-1.P3 | The cells are cultured under serum free condition that are derived from lymph node. Cells are sticky to culture dishes. | ||
rat | lymph node | JCRB0144.1B | LYM-1.P3B | Serum free FAR-2.F60 rat cell culture from lymph node near colon cancer. | ||
rat | lymph node | JCRB0144.1D | LYM-1.P3D | Serum free FAR-2.F60 rat cell culture from lymph node near colon cancer. | ||
rat:mammary Top | ||||||
rat | mammary | JCRB0242 | RMT-1 E4 | DMBA induced rat mammary carcinoma cell line. | ||
rat | mammary | JCRB0245 | RMT-1 M2 | Rat mammary carcinoma cell line from rat mammary gland induced by single shot DMBA(20mg) administrated by oral. | ||
rat:muscular system Top | ||||||
rat | muscular system | JCRB9081 | L6 | skeletal muscle myoblast | ||
rat | muscular system | IFO50364 | L6 | skeletal muscle myoblast | ||
rat | muscular system | JCRB0209 | L6TG | skeletal muscle myoblast, 6-thioguanine-resistant | ||
rat | muscular system | JCRB0210 | L6TG Cap | skeletal muscle myoblast, 6-thioguanine, chloramphencol-resistant | ||
rat:neural Top | ||||||
rat | neural | JCRB9096 | C6 | glial tumor, GFAP-positive | ||
rat | neural | IFO50110 | C6 | glial tumor, GFAP-positive | ||
rat | neural | IFO50425 | C6-SF2 | C6 subline adapted to serum-free medium | ||
rat | neural | IFO50490 | MDM2-RNB | human MDM2 protein-expressing astrocyte cell line, (Wistar rat) | ||
rat | neural | JCRB0733 | PC-12 | pheochromocytoma, , neuronal differentiation by NGF, adhesive variant | ||
rat | neural | IFO50278 | PC-12 | pheochromocytoma, neuronal differentiation by NGF, grow in suspension | ||
rat | neural | JCRB0130 | PC-12.P3 | Rat pheochromo cytoma cell line derived from adrenal medulla. Use serum free DM201 media. | ||
rat | neural | IFO50496 | PC-12TG | HAT-sensitive, 6-thioguanine-resistant. | ||
rat | neural | JCRB0130.1 | PC12.P3 | PC-12 derivative adapted to serum-free culture, direct deposition by original developer. | ||
rat | neural | JCRB0266 | PC12HS | Highly NGF sensitive clone of rat PC12 cell line. | ||
rat | neural | JCRB0263.1 | PC12HS.P3 | Serum free NGF sensitive PC12HS cell line. | ||
rat | neural | JCRB0268 | PC12IS | NGF insensitive clone of rat PC12 cell line. | ||
rat | neural | JCRB0267 | PC12MS | Moderately NGF sensitive clone of rat PC12 cell line. | ||
rat | neural | JCRB0129.1 | RCR-1 | Rat astrocyte-like cells producing GFAP. Serum free cell line (RCR-1.P3) is also available. | ||
rat | neural | JCRB0129.0 | RCR-1.P3 | Rat astrocyte-like cell line prducing GFAP in serum free cell culture. Parental strain of this cell line is also available(JCRB0129.1). | ||
rat | neural | IFO50491 | RNB | RNB cells are the parent cells of MDM2-RNB cells (IFO 50490). | ||
rat:pituitary Top | ||||||
rat | pituitary | JCRB9046 | GH1 | pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat) | ||
rat | pituitary | IFO50269 | GH1 | pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat) | ||
rat | pituitary | JCRB9047 | GH3 | pituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat) | ||
rat | pituitary | IFO50105 | GH3 | Rat pituitary tumor secreting somatotrophin. | ||
rat:sarcoma Top | ||||||
rat | sarcoma | JCRB1001.1 | MS-653-A | Highly metastatic rat fibrosarcoma cell line induced by methylcholanthrene. | ||
rat | sarcoma | JCRB1001.2 | MS-653-G | Rat fibrosarcoma cell line induced by methylcholanthrene. | ||
rat | sarcoma | JCRB0259 | MSK | osteosarcoma, 32P-induced, (F344 rat) | ||
rat | sarcoma | IFO50017 | XC | RSV-induced sarcoma, useful for assay of murine leukemia virus, (Wistar rat) | ||
rat:skin Top | ||||||
rat | skin | JCRB0005 | FRSK | Fetal rat skin keratinocyte cell line. | ||
rat:spleen Top | ||||||
rat | spleen | JCRB0423 | RS-A | spleen, spontaneously transformed cells, (Donryu rat) | ||
rat:squamous cell carcinoma Top | ||||||
rat | squamous cell carcinoma | JCRB0230 | SCC-131 | Rat squamous cell carcinoma cell line. | ||
rat | squamous cell carcinoma | JCRB0231 | SCC-158 | squamous cell carcinoma | ||
rat:submandibular gland Top | ||||||
rat | submandibular gland | JCRB1146 | RSMG-1 | Stem cell like cell line from female rat submandibular gland. | ||
rat:testis Top | ||||||
rat | testis | JCRB9064 | LC540 | Leydig cell testicular tumor | ||
rat | testis | JCRB9055 | R2C | Leydig cell testicular tumor,steroid secreting | ||
rat:thymus Top | ||||||
rat | thymus | IFO50078 | IT-26R21 | T cell differentiation factor producing, (Wistar rat) | ||
rat | thymus | IFO50076 | IT-45R1 | T cell differentiation factor producing, (Wistar rat) | ||
rat | thymus | IFO50077 | IT-45R91 | thymic fibroblast, (Wistar rat) | ||
rat | thymus | IFO50112 | TaD-1 | thymoma, keratin-positive, (ACI x BUF/Mna, F1 rat) | ||
rat | thymus | IFO50120 | TaD-1-3 | This cell line is a clone of TaD-1 cells (IFO 50112). | ||
rat | thymus | IFO50103 | TuD-1 | thymic stroma, keratin-positive, (ACI rat) | ||
rat | thymus | IFO50152 | TuD-1-3 | This cell line is a clone of TuD-1 cells (IFO 50103). | ||
rat:thyroid Top | ||||||
rat | thyroid | IFO50270 | 6-23 clone 6 | medullary thyroid carcinoma, neurotensin and calcitonin-producing, (WAG/RIJ rat) | ||
tupaia:lung Top | ||||||
Japan Domestic use only | tupaia | lung | JCRB0745 | T-23 clone 8 | normal, applicable for the mutation assay system in vitro |